好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | P6 - Poster Session 06

Tuesday 04/16/24
08:00 AM - 09:00 AM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, 好色先生, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neurocritical Care, Neuromuscular and Clinical Neurophysiology (EMG), Pain
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive
Event Timeline
08:00 AM - 09:00 AM MDT Abstract 9-001 - Biofluid Activity and Levels of the Angiotensin-converting Enzyme Are Surrogates for Diverse Cerebrospinal Fluid Amyloid-beta Effects in Dementia with Lewy Bodies and Alzheimer’s Dementia
Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FAAN, FAAN
08:00 AM - 09:00 AM MDT Abstract 9-002 - Nuclear Transport Receptors as Novel Modifiers of C9orf72 Pathology
Feilin Liu, MD
08:00 AM - 09:00 AM MDT Abstract 9-003 - Diagnostic Applications of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia
Gregory S. Day, MD, MSc, FAAN
08:00 AM - 09:00 AM MDT Abstract 9-004 - Medial Prefrontal Acetylcholine Release Is Modulated by Stimulus During Interval Timing
Qiang J. Zhang, MD
08:00 AM - 09:00 AM MDT Abstract 9-005 - The Relationship Between GSK3?eta Activity and TDP-43 Mediated Neuritis in Neurodegenerative Diseases
Eu Jene Choi, MD, PhD(c)
08:00 AM - 09:00 AM MDT Abstract 9-007 - The Neural Mechanism of Human Attention Shift
Mohammad Dastjerdi, MD
08:00 AM - 09:00 AM MDT Abstract 9-009 - Association of Metabolic Syndrome with the Development of Alzheimer’s Disease: A Systematic Review with Meta-analysis
Claudia Cruzalegui Bazán
08:00 AM - 09:00 AM MDT Abstract 9-010 - Computational Models of Age-associated Cognitive Slowing and Memory Loss
Sanya Ahmed
08:00 AM - 09:00 AM MDT Abstract 9-012 - Unraveling the Earliest Phases of Vascular Cognitive Impairment and Dementia by Establishing a Large USA CADASIL Consortium
Michael D. Geschwind, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 9-013 - A Challenging New Diagnosis of Neurofibromatosis Type-1 with Uncommon Vascular Manifestations in an Elderly Female
Isaac Smith, DO, MS
08:00 AM - 09:00 AM MDT Abstract 9-014 - Pathogenic Amyloid-beta Precursor Protein (APP) Duplication: A Rare Case of Early Onset Alzheimer's Dementia (EOAD) with Probable Cerebral Amyloid Angiopathy (CAA)
Alexander Maslov, MD
08:00 AM - 09:00 AM MDT Abstract 9-015 - A Clinical Puzzle: CSF1R Leukoencephalopathy Presenting with Aphasia and Behavior Change in the Guise of TBI Sequelae
Kyle R. Marden, MD
08:00 AM - 09:00 AM MDT Abstract 9-016 - Retrospective Study of Multi-site CADASIL: Implications for Clinical and Research Practice
Michael D. Geschwind, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 9-017 - Novel Stop-gain SORL1 Mutation in a Peruvian Family with Alzheimer's Disease of the PeADI Study
Mario R. Cornejo Olivas, MD
08:00 AM - 09:00 AM MDT Abstract 15-001 - Encephalitis of Unknown Etiology in Colombia: A Multicenter Case Series
David Acero-Garces, MD
08:00 AM - 09:00 AM MDT Abstract 15-002 - Estimating Income Loss from Neurological Disorders Globally, 1990–2019
Jeremy D. Dalos
08:00 AM - 09:00 AM MDT Abstract 15-004 - Military Service and Survival with Amyotrophic Lateral Sclerosis
Ian Tang, PhD
08:00 AM - 09:00 AM MDT Abstract 3-001 - The Impact of Social Determinants of Health in the Morbidity of Patients with Huntington Disease
Jorge E. Patino Murillas, MD
08:00 AM - 09:00 AM MDT Abstract 3-002 - A Unique Case of Late Adult Onset Dyskinesia due to Adenylyl Cyclase 5 Mutation
Gunjanpreet Kaur, MD
08:00 AM - 09:00 AM MDT Abstract 3-003 - The Impact of Antidopaminergic Medication on Longitudinal Clinical Progression in Huntington Disease
Randal Hand
08:00 AM - 09:00 AM MDT Abstract 3-004 - Dissemination of VMAT-2 Inhibitors: A New Class of Drug for Tardive Dyskinesia and Huntington’s Disease
Michiko K. Bruno, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-005 - Case Report: Two Patients of Mexican Heritage with Huntington’s Disease-like 2
Sarah Horn, MD
08:00 AM - 09:00 AM MDT Abstract 3-006 - Olfactory Dysfunction as an Indicator of Cognitive and Motor Impairment Severity in Huntington’s Disease
Shayan A. Zadegan, MD
08:00 AM - 09:00 AM MDT Abstract 3-008 - A Pilot Study to Evaluate the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease
Erin Furr-Stimming, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-009 - Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington’s Disease
Shuhei Shiino
08:00 AM - 09:00 AM MDT Abstract 3-010 - Preparatory Check to Assess Equipment and Participant Comfort Prior to a Televisit in Huntington’s Disease
Samuel A. Frank, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-011 - Late-onset Chorea Associated with Essential Thrombocythemia
Molly Perkins, MD
08:00 AM - 09:00 AM MDT Abstract 3-012 - How Robust Are Biomarkers for the Huntington Disease Continuum?
Maria Rudrud
08:00 AM - 09:00 AM MDT Abstract 3-013 - GAA-FGF14 Disease: Defining Its Frequency, Molecular Basis, and 4-aminopyridine Response in a Large Cohort of Patients with Downbeat Nystagmus
David Pellerin, MD
08:00 AM - 09:00 AM MDT Abstract 3-014 - Automated Video-based Characterization of Movement Quality in a Phase III Clinical Trial of Troriluzole in Subjects with Spinocerebellar Ataxia
Melissa Beiner
08:00 AM - 09:00 AM MDT Abstract 3-015 - Prevalence Estimation of the Main Spinocerebellar Ataxias in South America: A Meta-analysis Approach
Milagros Galecio-Castillo, MD
08:00 AM - 09:00 AM MDT Abstract 3-016 - Supra and Infratentorial Atrophy in Cerebellar Ataxias: Unveiling Distinctions Across Different Etiologies
Edoardo G. Spinelli, MD
08:00 AM - 09:00 AM MDT Abstract 3-017 - Spinocerebellar Ataxia 27B with Grip Myotonia: Case Report and Literature Review
Yasuko Mori, Sr., MD
08:00 AM - 09:00 AM MDT Abstract 3-018 - Foundation Sponsored Genetic Counseling and Testing Program for Spinocerebellar Ataxia (SCA) Types 1, 2, and 3: Analysis of the First Two Years of Service
Kelsey Trace, OTD
08:00 AM - 09:00 AM MDT Abstract 3-019 - Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy
Tina Liu, MD
08:00 AM - 09:00 AM MDT Abstract 3-020 - Deep Brain Stimulation in Spinocerebellar Ataxias: Review
Surabhi A. Garg, MD
08:00 AM - 09:00 AM MDT Abstract 12-001 - Long-term Safety and Tolerability of Zavegepant 10 mg Nasal Spray in the Acute Treatment of Migraine Among Female Adults
Samantha Sweeney, Other
08:00 AM - 09:00 AM MDT Abstract 12-002 - The Effect of Sodium Valproate as a Migraine Abortive: A Systematic Review and Network Meta-analysis
Victoria Damore
08:00 AM - 09:00 AM MDT Abstract 12-003 - Characterization of the Prevalence and Treatment Strategies of Migraine in Patients with Refractory Spontaneous Intracranial Hypotension
Ahmed Taha Shahzad
08:00 AM - 09:00 AM MDT Abstract 12-004 - Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine in Women: Results from 2 Randomized, Placebo-controlled Clinical Trials
Samantha Sweeney, Other
08:00 AM - 09:00 AM MDT Abstract 12-005 - Mexiletine for the Treatment of Refractory Chronic Migraine: A Retrospective Chart Review
Lucia Liao, MD
08:00 AM - 09:00 AM MDT Abstract 12-006 - EMERGE Study: An Open-label Evaluation of the Efficacy and Safety of AXS-07 (MoSEIC™ meloxicam-rizatriptan) for Migraine in Adults with Prior Inadequate Response to an Oral CGRP Inhibitor
Peter J. McAllister, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 12-007 - Pressure on Myofascial Trigger Points Reproduces Migraine and Tension Type Headache Phenotypes in Persistent Post-traumatic Headache: Implications of Physical Findings on the Physiology and Diagnosis of Headache Disorders
Michael R. Sorrell, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 12-008 - Prospective Observational Pilot Study of Low-dose Naltrexone in Patients with Chronic Migraine with Comorbid Fibromyalgia
Arashleen K. Pannu
08:00 AM - 09:00 AM MDT Abstract 12-009 - Efficacy of EP102 (Oral Fospropofol) for the Acute Treatment of Migraine in an Open-label Proof-of-concept Trial: Effect of Time to Treatment
Allen H H. Heller, MD, MPH
08:00 AM - 09:00 AM MDT Abstract 12-010 - Hemicrania continua successfully treated long-term with botulinum toxin type A: a case report
Fatima Traore, MD
08:00 AM - 09:00 AM MDT Abstract 6-001 - Understanding the Link Between Psoriasis and Multiple Sclerosis: A Systematic Review and Meta-analysis
Amr Salem, MBBCH
08:00 AM - 09:00 AM MDT Abstract 6-002 - Prevalence and Spectrum of Cognitive Phenotypes in Multiple Sclerosis and Related Risk Factors
Denise Diniz Carneiro
08:00 AM - 09:00 AM MDT Abstract 6-003 - Synaptic Injury in the IPL of the Retina Is a Predictor of Progression in Multiple Sclerosis
Christian Cordano, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 6-004 - A Sensor-based Data Capture Solution for Home-based Gait Assessment: The GAIT-HUB System
Timothy Ko
08:00 AM - 09:00 AM MDT Abstract 6-005 - Retinal Layer Thinning for Monitoring Disease-modifying Treatment in Relapsing Multiple Sclerosis—Evidence for Applying a Rebaselining Concept
Gabriel Bsteh, MD
08:00 AM - 09:00 AM MDT Abstract 6-006 - Use of a Machine Learning Model to Predict Disability Progression in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod
Ludwig Kappos, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-007 - Usability and Validation of Smartphone-based Neuroperformance Tests in Multiple Sclerosis
Katherine Beshears
08:00 AM - 09:00 AM MDT Abstract 6-008 - Reliability and External Validity of Digital Passive Gait Tracking in MS
Laurent Servais
08:00 AM - 09:00 AM MDT Abstract 6-009 - A Novel Methodology for Developing Smartphone-instrumented Tests for Assessing Movement, Dexterity, and Balance in Neurological Patients: Technical Verification of Ground Truth Datasets, and Analytical and Clinical Validation of Digital Biomarkers
Alejandro Ena Bernad
08:00 AM - 09:00 AM MDT Abstract 6-010 - Correlations Between Traditional Disability and Oculometric Measures in Multiple Sclerosis
Sarah Levy, PhD
08:00 AM - 09:00 AM MDT Abstract 6-011 - Prognostic Value of Serum Neurofilament Light Chain for Disease Activity in Patients with Relapsing Multiple Sclerosis: Results from Subgroup Analysis Based on Body Mass Index and Age from the Phase 3 ASCLEPIOS I/II Trials
Enrique Alvarez, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 6-012 - Exploring the Relationship Between Temperament Traits, Psychological Comorbidity, and Functional Disability Assessed with the WHOSAS 2.0 in Persons with Multiple Sclerosis
Carmenrita Infortuna
08:00 AM - 09:00 AM MDT Abstract 6-013 - Digital Facial Analysis Correlates with Mood and Cognitive Outcomes with People with MS
Alyssa Nylander, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 6-014 - Relapse-associated Worsening and Progression-independent Relapse Activity in Ozanimod-treated Participants with Relapsing Multiple Sclerosis from the RADIANCE and DAYBREAK Trials
Bruce A. Cree, MD, PhD, MAS, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-015 - Eight-point Reliable Change on Symbol Digit Modalities Test with Ozanimod: Findings from the Phase 3 SUNBEAM and DAYBREAK Extension Trials
James Appio
08:00 AM - 09:00 AM MDT Abstract 6-016 - Prognostic Factors of Disease Activity in Newly Diagnosed Teriflunomide-treated Patients with Multiple Sclerosis—A Nationwide Danish Study
Mie R. Mahler, MD
08:00 AM - 09:00 AM MDT Abstract 6-017 - Depression Symptoms Moderate Link Between Infratentorial and Cervical Cord T2 Lesions on Gait Speed in Relapsing-remitting Multiple Sclerosis
Hanaan Bing-Canar, PhD
08:00 AM - 09:00 AM MDT Abstract 7-001 - Neurology Residency Didactics: A Survey of Program Directors
Harry Sutherland, MD
08:00 AM - 09:00 AM MDT Abstract 7-002 - 好色先生 Priority Setting: A Multi-stakeholder Survey Study of the Didactic Curriculum of an Adult Neurology Residency Program
Sanem P. Uysal, MD
08:00 AM - 09:00 AM MDT Abstract 7-003 - Implementing and Assessing a Neuropalliative Communication Curriculum for Neurology Resident Physicians
Eileen Harrigan, MD
08:00 AM - 09:00 AM MDT Abstract 7-004 - Disseminating Neuropalliative Care 好色先生 via an Adaptable Curriculum: A Multi-site Feasibility Trial
Eileen Harrigan, MD
08:00 AM - 09:00 AM MDT Abstract 7-005 - Evaluating the Effectiveness of a Narrative Medicine Curriculum for Neurology Residents
Lauren K. Offerle, MD
08:00 AM - 09:00 AM MDT Abstract 7-006 - Curricular Needs Assessment and Application of Team-based Learning for Neurology Residency Curricular Gaps
Patricia Jokl Graese, MD
08:00 AM - 09:00 AM MDT Abstract 7-007 - X + Why: Rethinking the Neurology Residency Curriculum
Toni Cao, MD
08:00 AM - 09:00 AM MDT Abstract 7-008 - Variability in Brain Death 好色先生 Across US Neurology Residency Programs
Getasha Doobay, MD
08:00 AM - 09:00 AM MDT Abstract 1-001 - Seizures in the Leukodystrophies
Ashley N. Hackett, MD
08:00 AM - 09:00 AM MDT Abstract 1-002 - To Select or Not to Select: Evaluating the Effectiveness of the SeLECT Score in Predicting the Risk of Post-stroke Epilepsy: A Systematic Review
Muhammad Ahmed Ayaz, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-003 - An Analysis of Acute Seizure Presentation in Post-stroke Patients in the Emergency Department in Detroit
Melissa Ly, MD
08:00 AM - 09:00 AM MDT Abstract 1-004 - Description of Gastrointestinal Symptoms in Patients with New-onset Refractory Status Epilepticus (NORSE)
Anima Shrestha, MD
08:00 AM - 09:00 AM MDT Abstract 1-005 - EEG and Seizure Characteristics of Adults with Neurocysticercosis-associated Epilepsy at the University Teaching Hospital in Lusaka, Zambia
Melody T. Asukile, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-006 - Post-traumatic Epilepsy: Prevalence and Follow-up Among Trauma Patients
Daniel Kotas
08:00 AM - 09:00 AM MDT Abstract 1-007 - MindMapp: Revolutionizing Depression Diagnosis and Management Through EEG and AI Chatbot Integration
Abel M. Thomas
08:00 AM - 09:00 AM MDT Abstract 1-009 - Ictal Migraine Following Hemipsherectomy
Sudheesh Ramachandran, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-010 - Analysis of Real-world Characteristics of Patients with CDKL5 Deficiency Disorder Enrolled for Ganaxolone Treatment
John A. Flatt, MD
08:00 AM - 09:00 AM MDT Abstract 1-011 - Serotonin Syndrome Complicated by Status Epilepticus: A Literature Review
Muskan Rawoot, MD
08:00 AM - 09:00 AM MDT Abstract 1-012 - Concordance of Epileptiform Discharges on Video-electroencephalogram (EEG) with the Brain Imaging of Focal Lesions in Drug Resistant Epilepsy: Experience from a Tertiary Centre in India
Sidharth Suresh, MD, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-013 - Characteristics of Non-diagnostic Admissions to the Epilepsy Monitoring Unit
Nimit N. Desai, MD
08:00 AM - 09:00 AM MDT Abstract 1-014 - Utility of Tilt Table Testing in Management of Seizure-like Activity After Inconclusive Epilepsy Monitoring Unit Admission
Krystyna Cios, MD
08:00 AM - 09:00 AM MDT Abstract 1-015 - Effect of Standardized Neurologic and Psychiatric Evaluation on Prognosis for Patients Diagnosed with Functional Seizures in the Epilepsy Monitoring Unit: A Quality Improvement Initiative
Kelly A. Boylan, MD
08:00 AM - 09:00 AM MDT Abstract 1-016 - Long-term EEG Utilization After Ambulatory EEG?(aEEG)?versus Epilepsy Monitoring Unit (EMU)?Admission in US Veterans
Tae Kim, MD
08:00 AM - 09:00 AM MDT Abstract 10-001 - First Case of Optic Nerve Cavernoma in the United States Hispanic Population
Aygun Asgarli, MD
08:00 AM - 09:00 AM MDT Abstract 10-002 - A Child with Autosomal Recessive Leber Hereditary Optic Neuropathy
Nhayoung Hwang, MD
08:00 AM - 09:00 AM MDT Abstract 10-003 - Visual Manifestations in the Setting of Perinuclear Antineutrophilic Cytoplasmic Antibody (P-ANCA) Vasculitis
Naga Pradyumna Kothapalli, MD
08:00 AM - 09:00 AM MDT Abstract 10-004 - Lymphomatoid Granulomatosis Presenting with a Third Nerve Palsy
Philip T. Kuball, MD
08:00 AM - 09:00 AM MDT Abstract 10-005 - Downbeat Nystagmus in Patient with AQP4-positive Neuromyelitis Optica
Isabella Canut
08:00 AM - 09:00 AM MDT Abstract 10-006 - Isolated Downgaze Palsy in a Patient with Acute Pretectum Paramedian Midbrain and Left Thalamic Ischemic Infarctions: A Case Report
JoBeth D. Bingham, DO
08:00 AM - 09:00 AM MDT Abstract 4-001 - The First Report of Myoclonus and Putaminal Cysts in Salla Disease—The Phenotype Expanded
Esther Macken, MD
08:00 AM - 09:00 AM MDT Abstract 4-002 - Expounding a Rare Association Between Motor Neuron Disease and Parkinson-Plus Syndromes
Jason Gandhi, MD
08:00 AM - 09:00 AM MDT Abstract 4-003 - Superficial Siderosis of the Central Nervous System (SS-CNS): A Mimic of Motor Neurone Disease
Esther Macken, MD
08:00 AM - 09:00 AM MDT Abstract 4-004 - Neurologic Involvement in Cystinosis: Focus on Brain Lesions and New Evidence of Four-repeat (4R-) Tauopathy
Tommaso Nicoletti, MD
08:00 AM - 09:00 AM MDT Abstract 4-005 - Provider “B”-ware: Using Methylmalonic Acid Levels to Diagnose B12-deficiency Neuropathy
Sahil Naik, MD
08:00 AM - 09:00 AM MDT Abstract 4-006 - A Hard Pill to Swallow, Cenobamate-induced Neutrophilic Dermatoses Misdiagnosed as Neuro-sweet Syndrome
Maria Belen Solis Mayorga, MD
08:00 AM - 09:00 AM MDT Abstract 4-007 - Acute Idiopathic Syringomyelia
Ghazal Ahmad, MD
08:00 AM - 09:00 AM MDT Abstract 4-008 - Glioblastoma Chameleons: A Case Series of Sudden Onset Aphasia and Alexia Without Agraphia Secondary to Complications of Glioblastoma Initially Mimicking Stroke
Shuodan Zhang, MD
08:00 AM - 09:00 AM MDT Abstract 4-009 - Evaluation of Copy Number Losses in the MBD5 5’-Untranslated Region: Expression Matters
Karishma Kashyap
08:00 AM - 09:00 AM MDT Abstract 4-010 - Delayed Progressive Leukoencephalopathy and Rash in a Patient with Cocaine Use
Melanie Li, MD
08:00 AM - 09:00 AM MDT Abstract 4-011 - Peripheral Neural Correlates of Isolated Genital Numbness
Sarah Wright, PhD, MBChB
08:00 AM - 09:00 AM MDT Abstract 4-012 - Non-traumatic Cause of Brown-Sequard Syndrome: a Case Report
Rania Issa, MD
08:00 AM - 09:00 AM MDT Abstract 4-013 - Remarkable Improvement of Initially Devastating Post-SARS-CoV-2 Myelitis After Administration of Steroids and Plasmapheresis
Amra Sakusic, MD
08:00 AM - 09:00 AM MDT Abstract 13-001 - Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Anti-nerve Growth Factor (NGF) Antibody Tanezumab in Subjects with Moderate to Severe Pain Due to Schwannomatosis
Danielle Silverman
08:00 AM - 09:00 AM MDT Abstract 13-004 - Unraveling the Triple Helix of Spine Pain: Spine Pain Diagnosis Rates Correlate with At-level Degenerative Spinal Condition Diagnoses
Suraj Malhan, DO
08:00 AM - 09:00 AM MDT Abstract 13-008 - The Efficacy of Fibrolux Laser Therapy in Fibromyalgia
Wael Richeh, MD
08:00 AM - 09:00 AM MDT Abstract 13-009 - An Unusual Presentation of Meningitis
Lucy Gee, PhD
08:00 AM - 09:00 AM MDT Abstract 13-010 - Is it Really a Stroke? Cervical Spinal Abscess Presenting with Unilateral Weakness
Nezar Khatib, MD
08:00 AM - 09:00 AM MDT Abstract 5-001 - Meningiomatosis in a Patient with Cornelia de Lange Syndrome: A Case Study
Jessica White, MD
08:00 AM - 09:00 AM MDT Abstract 5-002 - Triple Century in a Century (Lhermitte–Duclos Disease) -The Tale of a CNS Tumor
Aparna Kalyani Pariyadath, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-003 - Double Trouble: Rare Multiple Femoral Nerve Schwannomma and Peripheral Neuropathy Respond to Immunosuppression in a Patient with Neurofibromatosis Type 2
Lydia Kauffman, MD
08:00 AM - 09:00 AM MDT Abstract 5-004 - Cough-headache as a Novel Presentation of Methotrexate Neurotoxicity
Philion Gatchoff, MD
08:00 AM - 09:00 AM MDT Abstract 5-005 - Optic Neuritis in a Case of Secondary Hemophagocytic Lymphohistocytosis
Priscilla Yan, MD
08:00 AM - 09:00 AM MDT Abstract 5-006 - An Unusual Case of Transverse Myelitis After Anti-CD19 CAR T Cell Therapy for a Patient with Diffuse Large B Cell Lymphoma
Hadi M. Mohammad Khanli, MD
08:00 AM - 09:00 AM MDT Abstract 5-007 - A Rare RASopathy: Neurofibromatosis Noonan Syndrome
Amber R. Hughes
08:00 AM - 09:00 AM MDT Abstract 5-008 - Unraveling the Diagnosis and Therapeutic Triumph in Intravascular CNS Lymphoma: A Case Report
Kajol H. Doshi, MD
08:00 AM - 09:00 AM MDT Abstract 5-009 - Angioimmunoblastic T Cell Lymphoma Presenting as Subacute Sensorimotor Peripheral Neuropathy
Nicholas J. Bellacicco, DO
08:00 AM - 09:00 AM MDT Abstract 5-011 - Identifying a Relationship Between Executive Dysfunction, Poor Sleep Hygiene/Sleep Apnea, and Ventriculomegaly in Cancer-related Cognitive Impairment (CRCI)
Rhonna S. Shatz, DO
08:00 AM - 09:00 AM MDT Abstract 5-012 - Intracerebral Hemorrhage Risk in Patients with Primary Brain Tumors Taking Direct Oral Anticoagulants as Compared with Low Molecular Weight Heparin
Surabhi Ranjan, MD
08:00 AM - 09:00 AM MDT Abstract 5-013 - Examining Rates of Pseudoprogression in Older Patients with Glioblastoma
Derek L. Chien
08:00 AM - 09:00 AM MDT Abstract 5-014 - Medical Comorbidities as Predictors of Survival in Glioblastoma
Justin D. Bessette
08:00 AM - 09:00 AM MDT Abstract 5-015 - The Effect of Various Tumor Characteristics on Symptoms Experienced by Glioblastoma Patients
Sreya Devarakonda
08:00 AM - 09:00 AM MDT Abstract 5-016 - A Prospective Cohort Study to Evaluate the Natural History of and Identify Risk Factors for the Development of Tumor-related Epilepsy (TRE)
Thomas Wychowski, MD
08:00 AM - 09:00 AM MDT Abstract 5-017 - Metabolic Risk Factors and Outcomes in Patients with Glioblastoma
Orwa Aboud, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 5-018 - Depression as Primary Symptom Presentation of Glioblastoma Multiforme: A Case Series
Jordanne Kirschke
08:00 AM - 09:00 AM MDT Abstract 5-019 - Strokes in Individuals with Primary Brain Glioma After Radiation Therapy Managed with Bevacizumab: A Subgroup Analysis of a Retrospective Cohort
Dylan T. Ryan, MD
08:00 AM - 09:00 AM MDT Abstract 5-020 - The Effect of Social Demographics on Optune Usage Amongst Patients with Glioblastoma
Sreya Devarakonda
08:00 AM - 09:00 AM MDT Abstract 5-021 - An Illustrative Case of Daratumumab-associated Leukoencephalopathy: A Rare but Important Complication of Anti-CD38 Therapy in Multiple Myeloma Patients
Dan Tong Jia, MD
08:00 AM - 09:00 AM MDT Abstract 5-022 - Managing Neurotoxicity in B-cell Maturation Antigen (BCMA)-directed Therapy: A Case-series Study
Ambar M. MORALES-RODRIGUEZ, MD
08:00 AM - 09:00 AM MDT Abstract 5-023 - An Interesting Presentation of a Blinatumomab-associated Neurological Event
Shivika Chandra, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 5-024 - Routine Cancer Imaging Detects Risk of Metastatic Spinal Cord Compression and Time to Fracture
My H. Nguyen
08:00 AM - 09:00 AM MDT Abstract 5-025 - Serum Neurofilament Light Chain (sNfL) as Potential Biomarker for Immune Check Point Inhibitor (ICI) Mediated Limbic Encephalitis – A Case Series
Anza Zahid, MD, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-027 - Rapidly Progressive Dementia and Extrapyramidal Symptoms Associated with Froin’s Syndrome due to Leptomeningeal Carcinomatosis
Neil R. Holland, MBBS, FAAN
08:00 AM - 09:00 AM MDT Abstract 5-028 - A Case of Primary Intracranial Spindle Cell Carcinoma with DICER-1 Mutation Presenting as Abnormal Leptomeningeal Enhancement in an Immunocompetent Patient
Bavica Gummadi, DO
08:00 AM - 09:00 AM MDT Abstract 5-029 - Chronic Myelomonocytic Leukemia (CMML) Presenting with Numb Chin Syndrome and Intractable Headache
Saori L. Haigo, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 5-030 - A Case of Reversible Cerebral Vasoconstriction Syndrome (RCVS) After Axitinib and Pembrolizumab Therapy
Saif S. Bawaneh, MD
08:00 AM - 09:00 AM MDT Abstract 5-031 - Cryptococcal Meningitis Misdiagnosed as Leptomeningeal Disease (LMD): A Case Series
Rutu Patel, PA
08:00 AM - 09:00 AM MDT Abstract 5-032 - Extracranial Metastases from High-grade Glioma – Two Case Reports
Jay-Jiguang Zhu, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 2-001 - Can Clinical Scores Predict the Presence of Hypoxic Ischemic Brain Injury on Early Head Computed Tomography After Cardiac Arrest?
Christine Nguyen
08:00 AM - 09:00 AM MDT Abstract 2-003 - Synthetic Fentanyl and Xylazine—The New Rogue Wave of the Opioid Crisis: A Neuroimaging Case Series of “Tranq-Dope” Overdoses
Nirmala Ghimirey, DO
08:00 AM - 09:00 AM MDT Abstract 2-004 - Treatment and Long-term Outcome of Lance-Adams Syndrome
Helena Xeros, MD
08:00 AM - 09:00 AM MDT Abstract 2-005 - Patterns of Cerebral Hemodynamic Changes After Out of Hospital Cardiac Arrest
May Zin Myint, MBBS
08:00 AM - 09:00 AM MDT Abstract 2-006 - Neurological Prognostication in Post-cardiac Arrest Patients: A Systematic Review
Yugant Khand, MBBS, DiMM
08:00 AM - 09:00 AM MDT Abstract 11-001 - Improving Measurement of Lung Function in ALS: The Results of the Pulmonary Function via Impedance Tomography (PuFIT) Study
Seward B. Rutkove, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 11-002 - Early Gastrostomy Versus Late Gastrostomy Tube Performed in ALS Patients Admitted with Aspiration Pneumonia in the United States
Baljinder Singh, MD
08:00 AM - 09:00 AM MDT Abstract 11-003 - Machine-learning Techniques Applied to F-wave Waveforms Can Predict the Likelihood and Survival of ALS Patients
Kevin A. Mazurek, PhD
08:00 AM - 09:00 AM MDT Abstract 11-004 - Sex-related Differences in ALS Survival and Progression: Insights from a Population-based Study
Maurizio Grassano, MD
08:00 AM - 09:00 AM MDT Abstract 11-005 - Upper Motor Neuron Involvement Examined by Triple Stimulation in Amyotrophic Lateral Sclerosis
Christian Krarup, MD, DMSc, FRcP, FAAN
08:00 AM - 09:00 AM MDT Abstract 11-006 - Use High-dimensional Immune Profiling to Study Peripheral Immune System and ALS Progression
Xiaoyan Li, MD
08:00 AM - 09:00 AM MDT Abstract 11-007 - Retrospective Observational Study of ALS-associated Genes and Their Variants
Pardis Pooshpas, MD
08:00 AM - 09:00 AM MDT Abstract 11-009 - Neurofilaments in Amyotrophic Lateral Sclerosis: A Systemic Review and Meta-analysis
Pashtun-Poh Shahim, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 11-010 - QRL-201-01—A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral Sclerosis
Angela L. Genge, MD
08:00 AM - 09:00 AM MDT Abstract 11-011 - Characterizing Patient Preferences, Satisfaction, and Quality of Care Across Health Care Models in Amyotrophic Lateral Sclerosis (ALS)
Ilene Hollin
08:00 AM - 09:00 AM MDT Abstract 11-013 - Internet-supervised Home-based Spirometry Through Telemedicine in Amyotrophic Lateral Sclerosis
Eufrosina I. Young, MD
08:00 AM - 09:00 AM MDT Abstract 11-014 - Brief Report on Juvenile Amyotrophic Lateral Sclerosis Cases in the United State National ALS Registry: 2010–2018
Moon Han, PhD
08:00 AM - 09:00 AM MDT Abstract 11-015 - Geographic Distribution of Amyotrophic Lateral Sclerosis (ALS) in the Chicagoland Area
Abeeha Mirza
08:00 AM - 09:00 AM MDT Abstract 11-016 - Amyotrophic Lateral Sclerosis (ALS) in Puerto Rico: An Overview
Frances M. Aponte-Caraballo, MS
08:00 AM - 09:00 AM MDT Abstract 11-017 - Chlorovirus Glycoproteins and SOD1G93A Significantly Enhance, While Cellular Proteins IRF3 and ERK MAP-kinase Significantly Dampen, Production of ALS-associated Inflammatory Factors from Murine Macrophages
Gary L. Pattee, MD
08:00 AM - 09:00 AM MDT Abstract 11-018 - Validating a Novel CSF-mediated Animal Model of Sporadic ALS
Sarah M. Kovalev, RA
08:00 AM - 09:00 AM MDT Abstract 11-019 - Evaluating the Safety, Tolerability, and Pharmacokinetics of QRL-101 in Two Phase 1 Studies: QRL-101-01 in Healthy Adults and QRL-101-02 in Adults with ALS
Angela L. Genge, MD
08:00 AM - 09:00 AM MDT Abstract 11-020 - The Use of Relyvrio in ALS Among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists
Blaine Cloud, PhD
08:00 AM - 09:00 AM MDT Abstract 14-001 - A Case of Thymoma-associated Paraneoplastic Encephalitis with Identification of a Novel Neuronal Antibody
Alexa L. Carreras, MD
08:00 AM - 09:00 AM MDT Abstract 14-002 - Long-lived Plasma Cells Associated with Relapsing Anti-NMDAR Encephalitis
Yue Liu
08:00 AM - 09:00 AM MDT Abstract 14-003 - Proteome Remodeling in a Peptide Immunization Animal Model of Anti-NMDAR Encephalitis
David R. Benavides, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 14-004 - Autonomic Dysfunction in Autoimmune Encephalitis: A Review of the Literature
Sophie Ohrn
08:00 AM - 09:00 AM MDT Abstract 14-005 - Treatment of Refractory Anti-NMDA Receptor Encephalitis with Daratumumab in Two Pediatric Patients
Amy Young, MD
08:00 AM - 09:00 AM MDT Abstract 14-006 - ECT in NMDAR Encephalitis: A Retrospective Cohort and Systematic Review of Literature
Melissa A. Wright, MD
08:00 AM - 09:00 AM MDT Abstract 14-007 - Characterization of Social Determinants of Health in Patients with Anti-NMDAR Encephalitis
Ka-Ho Wong
08:00 AM - 09:00 AM MDT Abstract 14-008 - Efficacy and Safety of Different Oral Prednisone Tapering Course in Anti-N-M-methyl-D-aspartate Receptor Encephalitis: A Multicenter Cohort Study
Linjun Cai, PhD
08:00 AM - 09:00 AM MDT Abstract 14-010 - Acute Autoimmune Limbic Encephalitis Associated with GABABR Antibody in a Patient with Advanced Squamous Cell Carcinoma of the Cervix Treated with Pembrolizumab: A Case Report
Shiv K. Jha, MBBS
08:00 AM - 09:00 AM MDT Abstract 14-011 - The Use of APE2 Score to Diagnose Autoimmune Encephalitis
Bijoya Basu
08:00 AM - 09:00 AM MDT Abstract 14-012 - Anti GABA-B Receptor Autoimmune Encephalitis Associated with Thymoma: Case Report
Reena Bastin, MD
08:00 AM - 09:00 AM MDT Abstract 14-013 - NMDA Receptor Encephalitis in a Transgender Patient: A Case Report and Literature Review
Christina Law, MD, MEd
08:00 AM - 09:00 AM MDT Abstract 14-014 - Non-convulsive Status Epilepticus due to LGI-1 Encephalitis Presenting as Intermittent Confusion
Hiromi Terai
08:00 AM - 09:00 AM MDT Abstract 14-015 - AMPA Receptor Encephalitis: A Decade-long Unveiling of Clinical, Radiographic, and Serological Findings in an Untreated Patient
Ahmad Mahadeen, MD
08:00 AM - 09:00 AM MDT Abstract 14-016 - Autoimmune Limbic Encephalitis in the Setting of TNF-Inhibitor Use for Crohn’s Disease
Zainab Al Obaidi, MD
08:00 AM - 09:00 AM MDT Abstract 14-017 - Case of Late Recurrence of Leucine-rich Glioma Inactivated-1 Protein IgG (LGI-1) Encephalitis: Highlighting Nuances of Long-term Medical Management of Autoimmune Antibody-mediated Encephalitis
Hannah Harrison, MD, MBA
08:00 AM - 09:00 AM MDT Abstract 14-018 - Late-onset Anti-NMDAr Encephalitis After HSV Encephalitis in Pregnancy
Ann Zheng, MD
08:00 AM - 09:00 AM MDT Abstract 14-019 - Case of LGI-1 Associated Encephalitis Presenting as Isolated Asymmetric Chorea
Meenakshi Roy, MD
08:00 AM - 09:00 AM MDT Abstract 14-020 - Initial MRI, EEG, and CSF White Cell Count Are Abnormal in Children with Anti-NMDA Receptor Encephalitis with Isolated Psychiatric Symptoms
Grace Gombolay, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 8-001 - Systemic Complications and Natural History of Aicardi Goutières Syndrome
Amanda Jan
08:00 AM - 09:00 AM MDT Abstract 8-002 - Diagnostic Journey and Therapeutic Intervention of a Type-1 Interferonopathy in a Newborn
Marie Varnet, MD
08:00 AM - 09:00 AM MDT Abstract 8-003 - Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
Monica Margoni
08:00 AM - 09:00 AM MDT Abstract 8-004 - Anti-NMDA Encephalitis Co-positive with Aquaporin 4 Antibodies in a 4-year-old Female
Chloe LaRochelle, MD
08:00 AM - 09:00 AM MDT Abstract 8-005 - Pediatric Seronegative NMOSD: A Case Series and Literature Review
Madison M. Patrick
08:00 AM - 09:00 AM MDT Abstract 8-006 - Diagnostic and Immunological Features of Post-Covid-19 Postural Orthostatic Tachycardia Syndrome in Children
Jinny O. Tavee, MD
08:00 AM - 09:00 AM MDT Abstract 8-007 - Safety and Tolerability of Intravenous Immunoglobulin Infusion in Down Syndrome Regression Disorder
Jonathan Santoro, MD
08:00 AM - 09:00 AM MDT Abstract 8-008 - A Case Report of Rapidly Fatal MOG Antibody-associated ADEM in a Pediatric Patient
Emily Allen
Faculty Disclosures
No disclosure on file
Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FAAN, FAAN Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gerson Lehrman Group. Dr. De Oliveira has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Atheneum Partners. Dr. De Oliveira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lionbridge. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman. Dr. De Oliveira has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Neurology® Video Journal Club Presenter with 好色先生.
Marjorie Miraldo No disclosure on file
Eduardo Castro-Neto No disclosure on file
Sandro Almeida No disclosure on file
Sandro Luiz de Andra Matas No disclosure on file
Paulo Bertolucci No disclosure on file
Maria Naffah-Mazzacoratti No disclosure on file
Feilin Liu, MD Dr. Liu has nothing to disclose.
Wilfried Rossoll No disclosure on file
Jorge C. Kattah, MD, FAAN Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Lindsey Kuchenbecker Lindsey Kuchenbecker has nothing to disclose.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Yuka Martens No disclosure on file
Matthew Brier, MD, PhD Dr. Brier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Brier has received research support from NIH.
Nihal Satyadev, MD, MPH Dr. Satyadev has nothing to disclose.
Steven R. Dunham, Jr., MD Dr. Dunham has nothing to disclose.
Evelyn Lazar, MD Dr. Lazar has nothing to disclose.
Maxwell Dacquel No disclosure on file
Rachel Henson No disclosure on file
Guojun Bu No disclosure on file
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Suzanne E. Schindler, MD, PhD Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schindler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Schindler has received research support from National Institute on Aging. Dr. Schindler has received personal compensation in the range of $0-$499 for serving as a Member of the Biospecimen Review Committee with National Centralized Repository for Alzheimer Disease. Dr. Schindler has a non-compensated relationship as a Board Member with Greater Missouri Alzheimer's Association that is relevant to AAN interests or activities.
Elizabeth Herries No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Qiang J. Zhang, MD The institution of Dr. Zhang has received research support from NIH/NIA.
Nandakumar Narayanan, MD, PhD Dr. Narayanan has nothing to disclose.
Braedon Kirkpatrick Braedon Kirkpatrick has nothing to disclose.
Eu Jene Choi, MD, PhD(c) Dr. Choi has nothing to disclose.
Matthew R. Burns, MD, PhD The institution of Dr. Burns has received research support from NIH. The institution of Dr. Burns has received research support from Mcknight Brain Institute.
Merritt Reece No disclosure on file
Hannah Phelps No disclosure on file
Mohammad Dastjerdi, MD Dr. Dastjerdi has nothing to disclose.
Regina Krel, MD No disclosure on file
Tejaswini Jagtap Ms. Jagtap has nothing to disclose.
Yana Krutoshinskaya, MD Dr. Krutoshinskaya has nothing to disclose.
Patricio Castro Suarez Mr. Castro Suarez has nothing to disclose.
Claudia Cruzalegui Bazán Miss Cruzalegui Bazán has nothing to disclose.
Mario G. Chavez Hermosilla Mr. Chavez Hermosilla has nothing to disclose.
Sanya Ahmed Ms. Ahmed has nothing to disclose.
Howard A. Crystal, MD, FAAN An immediate family member of Dr. Crystal has received personal compensation for serving as an employee of C4 TherAPEUTICS. An immediate family member of Dr. Crystal has stock in c4 THERAPEUTICS. Dr. Crystal has stock in c4 THERAPEUTICS.
William W. Lytton, MD Dr. Lytton has nothing to disclose.
Roberta J. Seidman, MD Dr. Seidman has nothing to disclose.
Chiara Giuseppina Bonomi No disclosure on file
Caterina Motta Caterina Motta has nothing to disclose.
Martina Poli No disclosure on file
Martina Gaia Di Donna No disclosure on file
Nicola Biagio Mercuri No disclosure on file
Giacomo Koch No disclosure on file
Alessandro Martorana No disclosure on file
Agnes Kowalska, MD Dr. Kowalska has nothing to disclose.
Jose Biller, MD, FACP, FAHA, FAAN Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Jamie Elliott, MD, PhD Dr. Elliott has nothing to disclose.
Suman Jayadev, MD Dr. Jayadev has nothing to disclose.
Stephen P. Salloway, MD, MS Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.
Jose Gutierrez, MD Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Sudha Seshadri, MD, FAAN Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Jennifer J. Majersik, MD, FAAN Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Karen D. Orjuela, MD, FAAN The institution of Dr. Orjuela has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Orjuela has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Orjuela has received research support from Abbott. The institution of Dr. Orjuela has received research support from NIH . The institution of Dr. Orjuela has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Orjuela has received research support from American Heart Association and Bristol Myers Squibb Foundation.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Helmi L. Lutsep, MD, FAAN Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Ihab Hajjar Ihab Hajjar has nothing to disclose.
Fanny M. Elahi, MD, PhD Dr. Elahi has nothing to disclose.
Henry J. Bockholt The institution of Henry Bockholt has received research support from NIH. The institution of an immediate family member of Henry Bockholt has received research support from NIH.
Jane S. Paulsen, PhD Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Wenyu Sun, MD No disclosure on file
Isaac Smith, DO, MS Dr. Smith has nothing to disclose.
Morris Jrada No disclosure on file
Alexander Maslov, MD Dr. Maslov has nothing to disclose.
James F. Rini, MD Dr. Rini has a non-compensated relationship as a Member on Advisory Board with Lilly that is relevant to AAN interests or activities. Dr. Rini has a non-compensated relationship as a Member on Advisory Board with CND Lifesciences that is relevant to AAN interests or activities.
Ariyana Bozzorg, MD Dr. Bozzorg has nothing to disclose.
Michelle Tsai, MD Dr. Tsai has nothing to disclose.
Paul B. Pritchard III, MD No disclosure on file
Kyle R. Marden, MD Dr. Marden has nothing to disclose.
Michael S. Jaffee, MD, FAAN Dr. Jaffee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society / New England Journal of Medicine Group. Dr. Jaffee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for McDermott, Will, and Emery on behalf of NCAA. The institution of Dr. Jaffee has received research support from NIH. Dr. Jaffee has received personal compensation in the range of $10,000-$49,999 for serving as a Director with American Board of Psychiatry and Neurology. Dr. Jaffee has received personal compensation in the range of $5,000-$9,999 for serving as a DoD study section member with Leidos in support of CDMRP.
Breton Asken Breton Asken has nothing to disclose.
Lee Kugelmann Lee Kugelmann has nothing to disclose.
DUANE DEDE No disclosure on file
Welton O'Neal, Jr., PharmD No disclosure on file
Jennifer Zitser-Koren, MD Dr. Zitser-Koren has nothing to disclose.
Iman Fathali No disclosure on file
Daven Crossland No disclosure on file
Michael Terranova Michael Terranova has nothing to disclose.
Theresa Driscoll No disclosure on file
Mirjana Djakovic No disclosure on file
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Scott Brittain No disclosure on file
Mario R. Cornejo Olivas, MD Dr. Cornejo Olivas has received research support from UNIVERSIDAD CIENTIFICA DEL SUR. The institution of Dr. Cornejo Olivas has received research support from CHDI. The institution of Dr. Cornejo Olivas has received research support from NIH. The institution of Dr. Cornejo Olivas has received research support from GP2/ASAP/MJFF. Dr. Cornejo Olivas has a non-compensated relationship as a Secretary elect with MDS-PAS that is relevant to AAN interests or activities.
Anthony J. Griswold, PhD Dr. Griswold has received research support from National Institutes of Health.
Ana Saldarriaga-Mayo Ana Saldarriaga-Mayo has nothing to disclose.
Pedro Mena Pedro Mena has nothing to disclose.
Richard S. Rodriguez No disclosure on file
Larry Adams No disclosure on file
Patrice Whitehead No disclosure on file
Rosario Isasi No disclosure on file
Maryenela Z. Illanes-Manrique, MD, Atlantic Fellow The institution of Dr. Illanes-Manrique has received research support from GLOBAL BRAIN HEALTH INSTITUTE.
Elison Sarapura-Castro, MD Dr. Sarapura-Castro has nothing to disclose.
Farid Rajabli, PhD Farid Rajabli has nothing to disclose.
Katalina McInerney Katalina McInerney has nothing to disclose.
Karina Milla-Neyra No disclosure on file
Carla Manrique Enciso No disclosure on file
Gary W. Beecham, PhD The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Sheila C. Suarez, MD Dr. Suarez has nothing to disclose.
Peter H. St George-Hyslop, MD, PhD Dr. St George-Hyslop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TransitionBio. The institution of Dr. St George-Hyslop has received research support from NIH. Dr. St George-Hyslop has received intellectual property interests from a discovery or technology relating to health care.
Ismael Araujo-Aliaga No disclosure on file
Michael L. Cuccaro No disclosure on file
Jeffery Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Alexa L. Carreras, MD Dr. Carreras has nothing to disclose.
Martha E. Orozco Cortes, MD Dr. Orozco Cortes has nothing to disclose.
Megan N. Thomas, MD Dr. Thomas has nothing to disclose.
Michael V. Robers, MD Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation.
Justin Hoskin, MD Dr. Hoskin has nothing to disclose.
Yue Liu Ms. Liu has nothing to disclose.
Zhen Hong, MD No disclosure on file
David R. Benavides, MD, PhD, FAAN The institution of Dr. Benavides has received research support from NIH/NINDS. The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd.
Yesenia Enriquez-Gonzalez, MD Dr. Enriquez-Gonzalez has nothing to disclose.
Andres Chavez-Barragan No disclosure on file
Timothy Zhang Timothy Zhang has nothing to disclose.
Sophie Ohrn Ms. Ohrn has nothing to disclose.
Rohan N. Patel Mr. Patel has nothing to disclose.
Andrew Bauerschmidt, MD Dr. Bauerschmidt has nothing to disclose.
Ahya S. Ali, MD Dr. Ali has nothing to disclose.
Franck Durif, MD, PhD No disclosure on file
Amy Young, MD Dr. Young has nothing to disclose.
abby kunz, MD Dr. Kunz has nothing to disclose.
Jordan Abbott No disclosure on file
Amanda L. Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Teri Schreiner, MD, MPH, FAAN The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Ryan Kammeyer, MD The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Melissa A. Wright, MD Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Mar Guasp, MD Dr. Guasp has nothing to disclose.
Christian Lachner Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView. Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group Services.
Grace Gombolay, MD, FAAN The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Maarten J. Titulaer, MD, PhD The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Sarah Shapiro Miss Shapiro has nothing to disclose.
Riya A. Soneji Miss Soneji has nothing to disclose.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Trieste Francis Miss Francis has nothing to disclose.
Tammy L. Smith, MD, PhD Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Abigail H. Sorenson Ms. Sorenson has nothing to disclose.
Jia Cheng No disclosure on file
Linjun Cai, PhD Linjun Cai has nothing to disclose.
Dong Zhou Dong Zhou has nothing to disclose.
Sobin Pant, MBBS Mr. Pant has nothing to disclose.
Sushil Yadav No disclosure on file
Gaurav Nepal Mr. Nepal has nothing to disclose.
Sijan Karki No disclosure on file
Bigyan Paudel No disclosure on file
Shiv K. Jha, MBBS Dr. Jha has nothing to disclose.
Hamza Khan-Tareen, MD Dr. Khan-Tareen has nothing to disclose.
Lauren Gluck, MD Dr. Gluck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeautics. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Rare Disease. Dr. Gluck has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Hesham A. Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Bijoya Basu Miss Basu has nothing to disclose.
Reena Bastin, MD Dr. Bastin has nothing to disclose.
Veronica Cipriani, MD No disclosure on file
Tobias Ruck No disclosure on file
Lara V. Marcuse, Sr., MD Dr. Marcuse has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Rory Abrams, MD Dr. Abrams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas Pharmaceutical.
Michelle Kaku, MD Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
DeWitt D. Pyburn, MD Dr. Pyburn has nothing to disclose.
Christina Law, MD, MEd Dr. Law has nothing to disclose.
Stefan Bittner Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Anvesh Balabhadra, MBBS Dr. Balabhadra has nothing to disclose.
Sanjay Mittal, MD Dr. Mittal has nothing to disclose.
Hiromi Terai Miss Terai has nothing to disclose.
Ragha Sakuru, MD Dr. Sakuru has nothing to disclose.
Ahmad Mahadeen, MD Dr. Mahadeen has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Zainab Al Obaidi, MD Dr. Al Obaidi has nothing to disclose.
Toluwanimi A. Shaanu, MBBS Dr. Shaanu has nothing to disclose.
Ahmad Al-Awwad, MD Dr. Al-Awwad has nothing to disclose.
Nidhiben A. Anadani, MD Dr. Anadani has nothing to disclose.
Hannah Harrison, MD, MBA Dr. Harrison has nothing to disclose.
Sarah E. Schmitt, MD, FAAN Dr. Schmitt has a non-compensated relationship as a President with American Board of Registered EEG Technologists -- LTM board that is relevant to AAN interests or activities.
Ann Zheng, MD Dr. Zheng has nothing to disclose.
Simona V. Proteasa, MD Dr. Proteasa has nothing to disclose.
Ivana Vodopivec, MD Dr. Vodopivec has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Vodopivec has received personal compensation for serving as an employee of Novartis. Dr. Vodopivec has stock in Roche.
Meenakshi Roy, MD Dr. Roy has nothing to disclose.
Christopher Goetz, MD, FAAN The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Sashank Prasad, MD Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.
James N. Brenton, MD, FAAN Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Jennifer H. Yang, MD Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. Dr. Yang has received research support from NIH.
Coral M. Stredny, MD Dr. Stredny has stock in Proctor and Gamble. The institution of Dr. Stredny has received research support from Pediatric Epilepsy Research Foundation.
Kristen Fisher, DO Dr. Fisher has nothing to disclose.
Alexander Sandweiss, MD, PhD Dr. Sandweiss has nothing to disclose.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society.
Tim Erickson No disclosure on file
Varun Kannan, MD Dr. Kannan has nothing to disclose.
Catherine E. Otten, MD The institution of Dr. Otten has received research support from CDC.
Claude Steriade, MD The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals. Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Speakers Bureau with SK Life Sciences. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Speakers Bureau with Neurelis. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Xenon Pharmaceuticals.
NgocHanh H. Vu, MD Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health.
Karla Robles Lopez Karla Robles Lopez has nothing to disclose.
Robert C. Goodrich III, MD Dr. Goodrich has nothing to disclose.
Scott I. Otallah, MD Dr. Otallah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck.
Janetta L. Arellano, MD Dr. Arellano has nothing to disclose.
Andrew Christiana, MD Dr. Christiana has nothing to disclose.
Morgan Morris Morgan Morris has nothing to disclose.
Alexandra B. Kornbluh, MD Dr. Kornbluh has nothing to disclose.
Ilana L. Kahn, MD Dr. Kahn has nothing to disclose.
Leigh N. Sepeta, PhD Dr. Sepeta has received personal compensation in the range of $500,000-$999,999 for serving as a Grant PI with Nih. Dr. Sepeta has a non-compensated relationship as a Special volunteer with Nih that is relevant to AAN interests or activities.
Eyal Muscal Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Yike Jiang Yike Jiang has nothing to disclose.
Kristy Murray No disclosure on file
Manikum Moodley, MD, FAAN Dr. Moodley has nothing to disclose.
Duriel I. Hardy, MD Dr. Hardy has nothing to disclose.
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Amanda Jan Mrs. Jan has nothing to disclose.
Isabella Barcelos No disclosure on file
Nicholson Modesti No disclosure on file
Sarah Woidill Sarah Woidill has nothing to disclose.
Francesco Gavazzi, MD, MD, PhD The institution of Dr. Gavazzi has received research support from NIH. The institution of Dr. Gavazzi has received research support from NIH, NINDS. The institution of Dr. Gavazzi has received research support from IONIS Pharmaceuticals.
David Isaacs No disclosure on file
Russell D'Aiello No disclosure on file
Anjana Sevagamoorthy No disclosure on file
Amy Pizzino No disclosure on file
Johanna Schmidt No disclosure on file
Keith Van Haren, MD Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Stephanie Keller, MD Dr. Keller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therpeutics. Dr. Keller has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Leukodystrophy Foundation. The institution of Dr. Keller has received research support from CHOP/NIH. The institution of Dr. Keller has received research support from IONIS. The institution of Dr. Keller has received research support from Biomarin. The institution of Dr. Keller has received research support from Boehring-Ingelheim.
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Lisa T. Emrick, MD Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Jamie L. Fraser, MD, PhD The institution of Dr. Fraser has received research support from NIH.
Justine Shults No disclosure on file
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Laura A. Adang, MD Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orchard Therapeutics.
Aparna Sarma, DO No disclosure on file
Marie Varnet, MD Dr. Varnet has nothing to disclose.
Saima Kayani, MD Dr. Kayani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogene. The institution of Dr. Kayani has received research support from Neurogene. The institution of Dr. Kayani has received research support from NIH.
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Alessandro Meani Alessandro Meani has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Damiano Mistri, MSC Mr. Mistri has nothing to disclose.
Mor Gueye No disclosure on file
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Chloe LaRochelle, MD Miss LaRochelle has nothing to disclose.
Carla D. Zingariello, DO The institution of Dr. Zingariello has received research support from ML Bio. The institution of Dr. Zingariello has received research support from Edgewise Therapeutics.
Kirsten Consing, DO Dr. Consing has nothing to disclose.
Felix M. Veloso, MD, FAAN No disclosure on file
Madison M. Patrick Ms. Patrick has nothing to disclose.
AJ Rathakrishnan No disclosure on file
Vikram Prakash, MD Dr. Prakash has nothing to disclose.
Homa Ebrahimi, MD No disclosure on file
Jinny O. Tavee, MD Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Sarah Petersen No disclosure on file
Sterling Kosmach No disclosure on file
Nathan Rabinovitch No disclosure on file
Saba Jafarpour, MD Dr. Jafarpour has nothing to disclose.
Mellad Khoshnood, MD Dr. Khoshnood has nothing to disclose.
Natalie Boyd Natalie Boyd has nothing to disclose.
Benjamin Vogel Benjamin Vogel has nothing to disclose.
Lina Nguyen Lina Nguyen has nothing to disclose.
Michael S. Rafii, MD, PhD Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Charles Jake Sadle, DO Dr. Sadle has nothing to disclose.
Amanda Rogers, MD An immediate family member of Dr. Rogers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medpace.
Erin Owen No disclosure on file
Emily Allen No disclosure on file
Harry Sutherland, MD Dr. Sutherland has received publishing royalties from a publication relating to health care.
Christine Gummerson, MD Dr. Gummerson has received personal compensation in the range of $0-$499 for serving as a NeuroBytes faculty contributor with 好色先生.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Fabio Nascimento, MD Dr. Nascimento has received publishing royalties from a publication relating to health care.
John Encandela No disclosure on file
Sanem P. Uysal, MD Dr. Uysal has nothing to disclose.
Carol Swetlik, MD An immediate family member of Dr. Swetlik has received personal compensation for serving as an employee of Pfizer. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Swetlik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Payal P. Soni, MD Dr. Soni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Robert J. Marquardt, DO Dr. Marquardt has nothing to disclose.
A. Blake Buletko, MD Dr. Buletko has nothing to disclose.
Lindsay Ross, MD Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapuetics. Dr. Ross has received publishing royalties from a publication relating to health care.
Cary L. Twyman, MD, FAAN No disclosure on file
Eileen Harrigan, MD Dr. Harrigan has nothing to disclose.
Brandon Giglio, MD Dr. Giglio has nothing to disclose.
Arielle M. Kurzweil, MD, FAAN Dr. Kurzweil has nothing to disclose.
Breana Taylor, MD Dr. Taylor has nothing to disclose.
Hannah Kirsch, MD An immediate family member of Dr. Kirsch has stock in Genentech.
Shivani Ghoshal, MD Dr. Ghoshal has nothing to disclose.
Kimberly Kwei, MD, PhD The institution of Dr. Kwei has received research support from New York Community Trust.
Kate T. Brizzi, MD Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Fern Health. Dr. Brizzi has received personal compensation in the range of $0-$499 for serving as a Consultant for Roon.
Claire Creutzfeldt, MD The institution of Dr. Creutzfeldt has received research support from NINR. The institution of Dr. Creutzfeldt has received research support from NIA.
Tarini Goyal Dr. Goyal has nothing to disclose.
Lauren K. Offerle, MD Dr. Offerle has nothing to disclose.
Shan E. Abbas, MD Dr. Abbas has nothing to disclose.
Denise Acevedo No disclosure on file
J.M.Monica Van De Ridder No disclosure on file
Emmy Abraham No disclosure on file
David H. Margolin, MD, PhD Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Patricia Jokl Graese, MD Dr. Graese has nothing to disclose.
Jeffrey B. Ratliff, MD, FAAN Dr. Ratliff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for the journal Neurology. The institution of Dr. Ratliff has received research support from Scion NeuroStim, LLC.
Andres Fernandez, MD Dr. Fernandez has nothing to disclose.
Lauren Canha No disclosure on file
Colin Dayan Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Provention Bio. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Colin Dayan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Colin Dayan has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Provention Bio. Colin Dayan has received intellectual property interests from a discovery or technology relating to health care.
Toni Cao, MD Dr. Cao has nothing to disclose.
Danny Bega, MD Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.
Katherine Carroll, MD Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Carolyn J. Bevan, MD Dr. Bevan has received intellectual property interests from a discovery or technology relating to health care.
Jasmine L. May, MD, PhD An immediate family member of Dr. May has received personal compensation for serving as an employee of Doximity. An immediate family member of Dr. May has stock in Doximity.
Ricky Lee, MD No disclosure on file
Getasha Doobay, MD Dr. Doobay has nothing to disclose.
Erin Barnes, MD An immediate family member of Dr. Barnes has received personal compensation for serving as an employee of Go2For Lung Cancer. The institution of Dr. Barnes has received research support from NIH.
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Rachel Beekman, MD Dr. Beekman has nothing to disclose.
Joshua Bonkowsky, MD, PhD Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Ashley N. Hackett, MD Dr. Hackett has nothing to disclose.
Eric J. Mallack, MD Dr. Mallack has received research support from NINDS.
Katie Liu No disclosure on file
Daniel C. Kelly Mr. Kelly has nothing to disclose.
Gabrielle T. Ghabash Ms. Ghabash has nothing to disclose.
Jordan Goodman No disclosure on file
William Benko, MD Dr. Benko has received personal compensation in the range of $500-$4,999 for serving as a Expert- Surveys with Connected Research .
Robert I. Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $500-$4,999 for serving as a Krabbe Disease expert with Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Dr. Thompson-Stone has a non-compensated relationship as a Editorial Board Member with Neurology: 好色先生 Journal that is relevant to AAN interests or activities.
Gerald Raymond, MD Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Seyed A. Fatemi, MD, MBA Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities.
Helena Yan, MD Ms. Yan has nothing to disclose.
Camille S. Corre, MD Dr. Corre has nothing to disclose.
Muhammad Ahmed Ayaz, MBBS Dr. Ayaz has nothing to disclose.
Muhammad Ibrahim Muhammad Ibrahim has nothing to disclose.
Ifrah Zawar, MD The institution of Dr. Zawar has received research support from Alzheimer's association. The institution of Dr. Zawar has received research support from American epilepsy society . The institution of Dr. Zawar has received research support from NIH. The institution of Dr. Zawar has received research support from University of Virginia.
Sameer Sharma, MD, MBBS Dr. Sharma has nothing to disclose.
Melissa Ly, MD Miss Ly has nothing to disclose.
Tabassum Chowdhury, MD Ms. Chowdhury has nothing to disclose.
Jason Liu, MD Mr. Liu has nothing to disclose.
Manik Tetarbe, MD Dr. Tetarbe has nothing to disclose.
Shatha Wahbi Ms. Wahbi has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
Juan Llibre No disclosure on file
Anima Shrestha, MD Miss Shrestha has nothing to disclose.
Lori Silveira No disclosure on file
Divya Thomas No disclosure on file
Jarrett Leech, MD Dr. Leech has nothing to disclose.
Yi-Chen Lai No disclosure on file
James J. Riviello, Jr., MD Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary.
Jason Soden No disclosure on file
Krista L. Eschbach, MD The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Melody T. Asukile, MBBS Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Mashina Chomba, MBChB Dr. Chomba has nothing to disclose.
Deanna Saylor, MD, MHS Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Mulenga Chilando Mulenga Chilando has nothing to disclose.
Frighton B. Mutete, MBChB Dr. Mutete has nothing to disclose.
Chimuka Muleya No disclosure on file
Theresa Shankanga Miss Shankanga has nothing to disclose.
Diwell Mwansa Diwell Mwansa has nothing to disclose.
Ndonji Chiwaya, MD Ndonji Chiwaya has nothing to disclose.
Mehmet Yaman, MD No disclosure on file
Willard Kasoff No disclosure on file
Daniel Kotas Mr. Kotas has nothing to disclose.
Hamza M. Ahmed, MBBS Dr. Ahmed has nothing to disclose.
S M Krishna M. Mavuru, MD, MBBS Dr. Mavuru has nothing to disclose.
Ramshekhar N. Menon, MD, MBBS, DM; PDF Dr. MENON has nothing to disclose.
Ashalatha Radhakrishnan, Sr., MD Dr. Radhakrishnan has nothing to disclose.
David A. Marks, MD Dr. Marks has nothing to disclose.
Nancy Song, MD Dr. Song has nothing to disclose.
Sudheesh Ramachandran, MBBS Dr. Ramachandran has nothing to disclose.
Martha Mulvey No disclosure on file
John Flatt No disclosure on file
Alex Aimetti No disclosure on file
Ian Miller, MD Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Muskan Rawoot, MD Ms. Rawoot has nothing to disclose.
Binod Wagle, MD, FAAN Dr. Wagle has nothing to disclose.
Suhaira Ahmad No disclosure on file
Makoto Ishii, MD, PhD Dr. Ishii has stock in Regeneron Pharmaceuticals. The institution of Dr. Ishii has received research support from NIH. The institution of Dr. Ishii has received research support from BrightFocus Foundation. The institution of Dr. Ishii has received research support from Alzheimer's Association. Dr. Ishii has received personal compensation in the range of $0-$499 for serving as a Author/Contributor with Relias Media.
Sidharth Suresh, MD, MBBS Dr. Suresh has nothing to disclose.
Manjari Tripathi, MD Dr. Tripathi has nothing to disclose.
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Rajesh Kumar Singh Rajesh Kumar Singh has nothing to disclose.
Arunmozhimaran Elavarasi, MD Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Jasmine Parihar, DM Dr. Parihar has nothing to disclose.
Shailesh Gaikwad Shailesh Gaikwad has nothing to disclose.
Madhavi Tripathi Madhavi Tripathi has nothing to disclose.
P Sarat Chandra P Sarat Chandra has nothing to disclose.
Costantino Iadecola, MD Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Nimit N. Desai, MD Dr. Desai has nothing to disclose.
Evangelos Pavlos Myserlis, MD The institution of Dr. Myserlis has received research support from 好色先生. Dr. Myserlis has received personal compensation in the range of $500-$4,999 for serving as a AAN Resident Scholarship to the Annual Meeting Recipient with 好色先生.
Pranav Patel No disclosure on file
Nan Jiang, MD Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for • Amylyx . Dr. Jiang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen .
Krystyna Cios, MD Ms. Cios has received research support from National Institutes of Health.
Mohankumar Kurukumbi, MD Dr. Kurukumbi has nothing to disclose.
Marc Wish No disclosure on file
Surbhi Mathur No disclosure on file
Jennifer Jolivert No disclosure on file
Grace Wu No disclosure on file
Erin C. Conrad, MD Dr. Conrad has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder. Dr. Conrad has stock in Humana. Dr. Conrad has stock in Lilly Eli. Dr. Conrad has stock in Medtronic. Dr. Conrad has stock in Merck. Dr. Conrad has stock in Nevro. Dr. Conrad has stock in Sanofi. Dr. Conrad has stock in United Health Group.
Kathryn A. Davis, MD Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals/Jazz Pharmaceuticals. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UNEEG. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Davis has received research support from Eisai. The institution of Dr. Davis has received research support from Liminal. Dr. Davis has received publishing royalties from a publication relating to health care.
Michael Gelfand, MD, PhD Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Consultant for Aquestive. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Dr. Gelfand has received research support from Aquestive. The institution of Dr. Gelfand has received research support from Xenon. The institution of Dr. Gelfand has received research support from Cerevel. The institution of Dr. Gelfand has received research support from UNEEG. The institution of Dr. Gelfand has received research support from Livanova. The institution of Dr. Gelfand has received research support from UCB. The institution of Dr. Gelfand has received research support from SK Pharma. The institution of Dr. Gelfand has received research support from Otsuka.
Eleanor Anderson No disclosure on file
Kelly A. Boylan, MD Dr. Boylan has nothing to disclose.
Tae Kim, MD Dr. Kim has nothing to disclose.
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
Marissa Kellogg, MD, MPH, FAAN The institution of Dr. Kellogg has received research support from VA & DoD.
Martin C. Salinsky, MD Dr. Salinsky has nothing to disclose.
David C. Spencer, MD, FAAN Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative 好色先生 Concepts.
Diana Angelika Olszewska, MD, PhD Dr. Olszewska has nothing to disclose.
Brian Sweeney, MD No disclosure on file
Antoinette O'Connor, MD Dr. O'Connor has nothing to disclose.
Noel Fanning No disclosure on file
Esther Macken, MD Dr. Macken has nothing to disclose.
Jason Gandhi, MD Dr. Gandhi has nothing to disclose.
Sandeep S. Rana, MD, FAAN Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSI. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pharmawrite. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Rana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Angela Kokkinis Angela Kokkinis has nothing to disclose.
Simon Cronin, PhD Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Carlo Rinaldi, MD, PhD No disclosure on file
Andrea Bink No disclosure on file
Birgit Helmchen No disclosure on file
Tommaso Nicoletti, MD Dr. Nicoletti has nothing to disclose.
Nils Briel, Jr., MD Dr. Briel has nothing to disclose.
Michael Weller, MD Dr. Weller has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurosense. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Philogen. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Weller has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure. The institution of Dr. Weller has received research support from Versameb.
Tibor Hortobagyi No disclosure on file
Hans Heinrich Jung, MD Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylan. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Aventis. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Jung has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Aventis. The institution of Dr. Jung has received research support from Swiss National Science Foundation.
Elisabeth Boudriot No disclosure on file
Benjamin Vlad No disclosure on file
Karl Frontzek No disclosure on file
Ariana Gaspert No disclosure on file
Anna Maria Reuss No disclosure on file
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Sahil Naik, MD Dr. Naik has nothing to disclose.
Sagar Mehta No disclosure on file
Rehana Persaud No disclosure on file
Shivani Naik, MD Dr. Naik has nothing to disclose.
Aparna M. Prabhu, MD Dr. Prabhu has nothing to disclose.
David A. Hammer, MD Dr. Hammer has nothing to disclose.
Njide Okubadejo, MD, FAAN The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Maria Belen Solis Mayorga, MD Dr. Solis Mayorga has nothing to disclose.
Hector Lalama, MD Dr. Lalama has nothing to disclose.
Michelanthony L. Rosado-Velazquez, Medical Student Mr. Rosado-Velazquez has nothing to disclose.
Daniel Moreno-Zambrano, MD Dr. Moreno-Zambrano has nothing to disclose.
Igor Khvylia, MD Mr. Khvylia has nothing to disclose.
Oluwadamilola O. Ojo, MD Dr. Ojo has nothing to disclose.
Ghazal Ahmad, MD Dr. Ahmad has nothing to disclose.
Mithilesh Siddu, MD Dr. Siddu has nothing to disclose.
Temitope A. Lawal, MD Dr. Lawal has nothing to disclose.
Shuodan Zhang, MD Dr. Zhang has nothing to disclose.
Stephanie Vu, MD Dr. Vu has nothing to disclose.
Patricia Greenstein, MD Dr. Greenstein has nothing to disclose.
Francis I. Ojini, MD No disclosure on file
Karishma Kashyap No disclosure on file
Mustapha A. Danesi, MD No disclosure on file
Melanie Li, MD Dr. Li has nothing to disclose.
Sarah Bou Reslan, MD Dr. Bou Reslan has nothing to disclose.
Lindsay Tetreault, MD, PhD Dr. Tetreault has nothing to disclose.
Elina Zakin, MD, FAAN The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Sarah Wright, PhD, MBChB Dr. Wright has nothing to disclose.
Jalesh Panicker Jalesh Panicker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coloplast . Jalesh Panicker has received publishing royalties from a publication relating to health care.
Sara Simeoni No disclosure on file
Prasad Malladi No disclosure on file
Sachin Kedar, MD, FAAN Dr. Kedar has nothing to disclose.
Rania Issa, MD Dr. Issa has nothing to disclose.
Aliyah Mohammed No disclosure on file
Ali Pourmand Ali Pourmand has nothing to disclose.
Jessica E. Rexach, MD, PhD Dr. Rexach has nothing to disclose.
Amra Sakusic, MD Dr. Sakusic has nothing to disclose.
Mohammed K. Badi, MD Dr. Badi has nothing to disclose.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
David Acero-Garces, MD Dr. Acero-Garces has nothing to disclose.
Susana Dominguez Penuela, MD Dr. Dominguez Penuela has nothing to disclose.
Beatriz Parra Beatriz Parra has nothing to disclose.
Lyda Osorio Lyda Osorio has nothing to disclose.
Martha Moyano Martha Moyano has nothing to disclose.
Jorge Angarita, MD Dr. Angarita has nothing to disclose.
Jose Enrique Vargas Manotas, MD, MSc Dr. Vargas Manotas has nothing to disclose.
Jorge Jimenez Jorge Jimenez has nothing to disclose.
Reydmar Lopez Reydmar Lopez has nothing to disclose.
Guillermo Gonzalez-Manrique Guillermo Gonzalez-Manrique has nothing to disclose.
Christian Rojas Cerón Christian Rojas Cerón has nothing to disclose.
JUAN ROJAS JUAN ROJAS has nothing to disclose.
FERNANDO ROSSO No disclosure on file
Viviana Martinez Viviana Martinez has nothing to disclose.
Jonathan Urrego Jonathan Urrego has nothing to disclose.
Federico Silva Federico Silva has nothing to disclose.
Angela Catalina Vallejo Cajigas, MD Dr. Vallejo Cajigas has nothing to disclose.
Cindy Beltran No disclosure on file
Jaime Quintero No disclosure on file
Julie Benavides Julie Benavides has nothing to disclose.
Daniela Zuluaga Lotero No disclosure on file
Jose Enciso No disclosure on file
Katherine Claros Katherine Claros has nothing to disclose.
Thanya Lagos Thanya Lagos has nothing to disclose.
Maria Fernanda Ramos Sanchez No disclosure on file
Jenny P. Garzon, MD Dr. Garzon has nothing to disclose.
DIEGO FRANCISCO LIZARAZO ORTEGA No disclosure on file
Jairo Lizarazo Niño Jairo Lizarazo Niño has nothing to disclose.
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Jeremy D. Dalos Mr. Dalos has nothing to disclose.
Ian Cogswell Ian Cogswell has nothing to disclose.
AJ Mitchell, PhD Dr. Mitchell has nothing to disclose.
Joseph Dieleman, PhD Prof. Dieleman has nothing to disclose.
Angela Apeagyei Angela Apeagyei has nothing to disclose.
Golsum Tsakalos Golsum Tsakalos has nothing to disclose.
Daniel T. Laskowitz, MD No disclosure on file
Abdulrahman O. Al Harbi, MD Dr. Al Harbi has nothing to disclose.
Norah Almuzil No disclosure on file
Rand M. Alanazi Ms. Alanazi has nothing to disclose.
Salma Almutairi No disclosure on file
Zihan Sun No disclosure on file
Ian Tang, PhD Dr. Tang has received research support from NIH.
Joanne Wuu, SCM The institution of Ms. Wuu has received research support from NIH NINDS. The institution of Ms. Wuu has received research support from NIH NCATS/NINDS. The institution of Ms. Wuu has received research support from CDC. The institution of Ms. Wuu has received research support from Target ALS. The institution of Ms. Wuu has received research support from ALS Recovery Fund. The institution of Ms. Wuu has received research support from NIH/NINDS. The institution of Ms. Wuu has received research support from NIH NINDS. The institution of an immediate family member of Ms. Wuu has received research support from NIH NINDS.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $0-$499 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Canopy. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alaunos. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Marc Weisskopf, PhD Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
Stefan M. Pulst, MD, FAAN Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Timothy R. Smith, MD The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Robert Fountaine Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has or had stock in Pfizer, Inc.Robert Fountaine has or had stock in Viatris, Inc.
Linda Mosher No disclosure on file
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
James Kelbert Mr. Kelbert has nothing to disclose.
Joshua Tobin, MD, FAAN An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
Victoria Damore Miss Damore has nothing to disclose.
George R. Wilmot, MD, PhD Dr. Wilmot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar Therapeutics. The institution of Dr. Wilmot has received research support from Friedrich Ataxia Research Alliance. The institution of Dr. Wilmot has received research support from National Ataxia Foundation. The institution of Dr. Wilmot has received research support from NIH. The institution of Dr. Wilmot has received research support from Reata. The institution of Dr. Wilmot has received research support from Biohaven Pharmaceuticals.
Hsiangkuo Yuan, MD, PhD An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
Simy K. Parikh, MD Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical 好色先生 (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Victor Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Ahmed Taha Shahzad Mr. Shahzad has nothing to disclose.
Christopher Gomez, MD, PhD Dr. Gomez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Gomez has received research support from Nih.
Kathleen B. Mullin, MD Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Lucia Liao, MD Dr. Liao has nothing to disclose.
Dylan A. Selbst Mr. Selbst has nothing to disclose.
Emily Casaletto Miss Casaletto has nothing to disclose.
Clinton G. Lauritsen, MD Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lauritsen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
Henry L. Paulson, MD, PhD, FAAN Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' 好色先生 Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical 好色先生. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research 好色先生 Social Awareness and Training In Neurosciences.
Angad Chhabra Angad Chhabra has nothing to disclose.
Caroline Streicher Caroline Streicher has received personal compensation for serving as an employee of Axsome Therapeutics. Caroline Streicher has stock in Axsome Therapeutics.
Gregory S. Parks, PhD Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Herriot Tabuteau Herriot Tabuteau has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Axsome Therapeutics.
Vikram Shakkottai, MD, PhD The institution of Dr. Shakkottai has received research support from National Institutes of Health. Dr. Shakkottai has received publishing royalties from a publication relating to health care.
Michael R. Sorrell, MD, FAAN Dr. Sorrell has nothing to disclose.
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Nathalia Figueiredo, MD Dr. Figueiredo has nothing to disclose.
Arashleen K. Pannu Ms. Pannu has nothing to disclose.
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Joshua Katz No disclosure on file
Samantha D'souza No disclosure on file
Rashiqah Syed No disclosure on file
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Allen H H. Heller, MD, MPH Dr. Heller has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Epalex Corporation. Dr. Heller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aquestive Therapeutics Inc.. Dr. Heller has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celanese Corporation. Dr. Heller has stock in Epalex Corporation.
Michael A. Rogawski, MD, PhD Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Kathryn Emily No disclosure on file
Fatima Traore, MD Dr. Traore has nothing to disclose.
Lucas Restrepo, MD, PhD Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Nassim Zecavati, MD, FAAN Dr. Zecavati has nothing to disclose.
Jacqueline Urtecho, MD Dr. Urtecho has nothing to disclose.
Lucy Gee, PhD Dr. Gee has nothing to disclose.
Claire Zurlo No disclosure on file
Devin Weber No disclosure on file
Nezar Khatib, MD Dr. Khatib has nothing to disclose.
Sadia Waheed, MBBS Dr. Waheed has nothing to disclose.
Mohammed Qureshi, MD Dr. Qureshi has nothing to disclose.
Emaan Fawad, Other Miss Fawad has nothing to disclose.
Fajar Fawad, Other Miss Fawad has nothing to disclose.
Fawad Yousuf, MBBS Dr. Yousuf has nothing to disclose.
Jorge E. Patino Murillas, MD Dr. Patino Murillas has nothing to disclose.
Natalia Pessoa Rocha Natalia Pessoa Rocha has nothing to disclose.
Shayan A. Zadegan, MD Dr. Zadegan has nothing to disclose.
Brittany Duncan No disclosure on file
Ryan Ramphul Ryan Ramphul has nothing to disclose.
Anjail Sharrief, MD The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Erin Furr-Stimming, MD, FAAN Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Gunjanpreet Kaur, MD Dr. Kaur has nothing to disclose.
Wilson E. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Xiaoyi Gao, MD Miss Gao has nothing to disclose.
Pratap R. Chand, MD, FRCP, FAAN Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience.
Michal Geva Michal Geva has received personal compensation for serving as an employee of Prilenia Therapeutics. Michal Geva has received intellectual property interests from a discovery or technology relating to health care.
Randal Hand Dr. Hand has received personal compensation for serving as an employee of Prilenia Therapeutics.
Paul Goldberg Paul Goldberg has received personal compensation for serving as an employee of Prilenia. Paul Goldberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis Pharmaceuticals. Paul Goldberg has stock in Prilenia.
Michael Hayden Michael Hayden has received personal compensation for serving as an employee of Prilenia Therapeutics. Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CAMP4. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for AbCellera Biologics Inc.. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Ionis Pharmaceuticals . Michael Hayden has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 89 Bio. Michael Hayden has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Oxford Biomedica . Michael Hayden has stock in Ionis Pharmaceuticals. Michael Hayden has stock in AbCellera Biologics Inc.. Michael Hayden has stock in 89 Bio. The institution of Michael Hayden has received research support from Canadian Institutes of Health Research. The institution of Michael Hayden has received research support from National Research Council Canada. The institution of Michael Hayden has received research support from Huntington Society of Canada. The institution of Michael Hayden has received research support from Bev Hartig Huntington Disease Foundation. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care. Michael Hayden has received intellectual property interests from a discovery or technology relating to health care.
Michiko K. Bruno, MD, FAAN The institution of Dr. Bruno has received research support from Michael J. Fox Foundation . The institution of Dr. Bruno has received research support from PIKO. The institution of Dr. Bruno has received research support from CurePSP. The institution of Dr. Bruno has received research support from Parkinson's Foundation .
Emma Krening, Other Ms. Krening has nothing to disclose.
Erica Ma No disclosure on file
Naotoshi Yamamura No disclosure on file
Sarah Horn, MD Dr. Horn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Horn has received research support from Alzheimer's Association.
Chintal T. Patel, MD Ms. Patel has nothing to disclose.
Kiyonori Kai No disclosure on file
Madilyn L. Feik Miss Feik has nothing to disclose.
Hannah Coco No disclosure on file
Andi Liang, MD Miss Liang has nothing to disclose.
Frank Ramirez Mr. Ramirez has nothing to disclose.
Sheng-Han Kuo, MD, FAAN Dr. Kuo has nothing to disclose.
Christopher Ross, MD, PhD Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniqure. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitoconix. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuCell. Christopher Ross, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuBase. Christopher Ross, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Christopher Ross, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Mintz. Christopher Ross, MD, PhD has received intellectual property interests from a discovery or technology relating to health care. Christopher Ross, MD, PhD has a non-compensated relationship as a consultant with Huntington Study Group that is relevant to AAN interests or activities.
Benjamin Hoehn Benjamin Hoehn has received personal compensation for serving as an employee of Annexon.
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to AAN interests or activities.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Victor W. Sung, MD Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Sung has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure.
Edward J. Wild, MBBS, PhD, MRCP Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon Biosciences. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teitur Trophics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Remix Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman La Roche. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Triplet Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vico Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Wild has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HDBuzz (a registered non-profit). The institution of Dr. Wild has received research support from CHDI Foundation (non-profit). The institution of Dr. Wild has received research support from Hoffman La Roche Ltd.
Sarah J. Tabrizi, MD, PhD Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd. Sarah J. Tabrizi, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Jeffrey D. Long Jeffrey Long has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Triplet. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vacinnex. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave. Jeffrey Long has received personal compensation in the range of $0-$499 for serving as a Consultant for PTC. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Jeffrey Long has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Jeffrey Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Jeffrey Long has received research support from NIH DSMB.
Marta Schumacher No disclosure on file
Brian Mangal No disclosure on file
Peter Collins Peter Collins has received personal compensation for serving as an employee of Annexon Biosciences. An immediate family member of Peter Collins has received personal compensation for serving as an employee of Wikipedia.
Glenn Morrison, PhD Dr. Morrison has received personal compensation for serving as an employee of Alector. Dr. Morrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG . Dr. Morrison has stock in Alector. Dr. Morrison has received intellectual property interests from a discovery or technology relating to health care.
Deepa Dongarwar Deepa Dongarwar has nothing to disclose.
Shuhei Shiino Mr. Shiino has nothing to disclose.
Daniel Kim No disclosure on file
Paul Slaughter No disclosure on file
Kaitlyn Hay No disclosure on file
Claudia Raines No disclosure on file
Christina Durrough No disclosure on file
Kristina Vaughn No disclosure on file
Michael De Riesthal No disclosure on file
Antje Mefferd No disclosure on file
Amy Brown, MD Dr. Brown has nothing to disclose.
Samuel A. Frank, MD, FAAN Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
Peggy Auinger Ms. Auinger has nothing to disclose.
John Stone No disclosure on file
Jason Kimmerly No disclosure on file
Elise P. Kayson, RN Elise Paulin Kayson, RN has nothing to disclose.
Jody Goldstein No disclosure on file
Nishel Y. Kothari, MBBS Dr. Kothari has nothing to disclose.
Molly Perkins, MD Dr. Perkins has nothing to disclose.
Phyllis Faust Phyllis Faust has nothing to disclose.
Alex Pinto No disclosure on file
Maria Rudrud No disclosure on file
Natalie Bovin No disclosure on file
William Adams No disclosure on file
Michael Newton No disclosure on file
H. Bockholt No disclosure on file
Esha Mahalingam No disclosure on file
Kathleen M. Shannon, MD, FAAN The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Monica L. Janz, MD Miss Janz has nothing to disclose.
Yuka Koike No disclosure on file
David Pellerin, MD Dr. Pellerin has nothing to disclose.
Felix Heindl Felix Heindl has nothing to disclose.
Carlo Wilke No disclosure on file
Matt Danzi Matt Danzi has nothing to disclose.
Andreas Traschutz, MD No disclosure on file
Catherine Ashton, MBBS Dr. Ashton has nothing to disclose.
Marie-Josee Dicaire Marie-Josee Dicaire has nothing to disclose.
Alexanne Cuillerier No disclosure on file
Giulia Del Gobbo No disclosure on file
Kym Boycott No disclosure on file
Jens Claassen No disclosure on file
Annette Hartmann Annette Hartmann has nothing to disclose.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Bernard Brais, MD Dr. Brais has nothing to disclose.
Michael Strupp, MD, DO, FAAN Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
Matthis Synofzik Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Dan Rujescu Dan Rujescu has nothing to disclose.
Masato Kanazawa, MD, FAAN Dr. Kanazawa has nothing to disclose.
Melissa Beiner Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
Evangelos Oikonomou No disclosure on file
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Rohan Khera No disclosure on file
Michele Potashman, PhD Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Kenshi Terajima, MD, PhD No disclosure on file
Milagros Galecio-Castillo, MD Dr. Galecio-Castillo has nothing to disclose.
Mahmoud Dibas, MD Mr. Dibas has nothing to disclose.
Silvia Basaia Silvia Basaia has nothing to disclose.
Stefano Pisano, MD Dr. Pisano has nothing to disclose.
Olivera Tamas No disclosure on file
Sarlota Mesaros Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sarlota Mesaros has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Hemofarm. Sarlota Mesaros has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Natasa Dragasevic No disclosure on file
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Yasuko Mori, Sr., MD Dr. Mori has nothing to disclose.
Satoko Miyatake No disclosure on file
Kenjiro Kunieda Kenjiro Kunieda has nothing to disclose.
Nobuaki Yoshikura, MD, PhD Dr. Yoshikura has nothing to disclose.
Yuichi Hayashi No disclosure on file
Kazuhiro Higashida Kazuhiro Higashida has nothing to disclose.
Akio Kimura, MD Dr. Kimura has nothing to disclose.
Eriko Koshimizu No disclosure on file
Naomichi Matsumoto No disclosure on file
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Kelsey Trace, OTD Dr. Trace has received personal compensation for serving as an employee of National Ataxia Foundation.
Michelle Hearn No disclosure on file
Celeste Suart No disclosure on file
Natalie Beck Natalie Beck has nothing to disclose.
Lauren Moore, PhD Dr. Moore has nothing to disclose.
Masatoyo Nishizawa, MD No disclosure on file
Tina Liu, MD Dr. Liu has nothing to disclose.
William Harmsen William Harmsen has nothing to disclose.
Lauren Jackson, MD Dr. Jackson has nothing to disclose.
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Wolfgang Singer, MD, FAAN Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth A. Coon, MD, FAAN Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Monica K. Johnson, MD Dr. Johnson has a non-compensated relationship as a Advisory Board Member with LiveOn OPO that is relevant to AAN interests or activities.
Negin Badihian, MD Dr. Badihian has nothing to disclose.
Mariana Suarez No disclosure on file
Fadi K. Abou-Mrad, MD, PhD, FAAN Dr. Abou-Mrad has nothing to disclose.
Japleen Kaur, MBBS Dr. Kaur has nothing to disclose.
Surabhi A. Garg, MD Dr. Garg has nothing to disclose.
Siddharth Agrawal No disclosure on file
Victoria Leavitt, PhD, FAAN Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Yang Yi No disclosure on file
Rachel Galioto Rachel Galioto has nothing to disclose.
Alexander Ratzan No disclosure on file
Denise Diniz Carneiro Denise Diniz Carneiro has nothing to disclose.
Marcos Aleandre Carneiro No disclosure on file
Andreia Mendonca No disclosure on file
Christian Cordano, MD, PhD Dr. Cordano has nothing to disclose.
Sebastian Werneburg No disclosure on file
Daniel Bennett No disclosure on file
Ahmed Abdelhak, MD The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
Alexandra Beaudry-richard Alexandra Beaudry-richard has received research support from the Multiple Sclerosis Society of Canada. Alexandra Beaudry-richard has received research support from the Canadian Institutes of Health Research .
Greg Duncan No disclosure on file
Frederike Cosima Oertel, MD The institution of Dr. Oertel has received research support from AAN. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
John Boscardin No disclosure on file
Hao Yiu No disclosure on file
Nora Jabassini No disclosure on file
Lauren Carito No disclosure on file
Sonia Nocera No disclosure on file
Jung Sin No disclosure on file
Shivany Condor Montes No disclosure on file
Kirtana Ananth An immediate family member of Kirtana Ananth has received personal compensation in the range of $10,000-$49,999 for serving as a Whole Time Member with Securities and Exchange Board of India (SEBI).
Antje Bischof, MD Dr. Bischof has nothing to disclose.
Bardia Nourbakhsh, MD Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Nourbakhsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. The institution of Dr. Nourbakhsh has received research support from Genentech. The institution of Dr. Nourbakhsh has received research support from National MS Society . The institution of Dr. Nourbakhsh has received research support from Department of Defense. The institution of Dr. Nourbakhsh has received research support from NIH. The institution of Dr. Nourbakhsh has received research support from Axsome Therapeutics. The institution of Dr. Nourbakhsh has received research support from TG Therapeutics .
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Ben Emery No disclosure on file
Jonah Chan, PhD Jonah Chan, PhD has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Contineum Therapeutics. Jonah Chan, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SFN. Jonah Chan, PhD has stock in Contineum Therapeutics. The institution of Jonah Chan, PhD has received research support from Mead Johnson. Jonah Chan, PhD has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH/NINDS.
Dorothy Schafer No disclosure on file
Ari Green, MD Dr. Green has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline Therapeutics. Dr. Green has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from NINDS. The institution of Dr. Green has received research support from NMSS. The institution of Dr. Green has received research support from NIA. The institution of Dr. Green has received research support from Adelson Research Foundation. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. Dr. Green has received personal compensation in the range of $500-$4,999 for serving as a Study Section with NINDS. Dr. Green has a non-compensated relationship as a Author with Viela Bio that is relevant to AAN interests or activities.
Timothy Ko Timothy Ko has nothing to disclose.
Erica Kreisberg No disclosure on file
Luis Fernandez No disclosure on file
Josef M. Gutman, MD Dr. Gutman has nothing to disclose.
Carrie Sammarco Carrie Sammarco has nothing to disclose.
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Tyler E. Smith, MD Dr. Smith has received research support from National Multiple Sclerosis Society. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a neurobytes author with 好色先生.
Giuseppina Pilloni, PhD Dr. Pilloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceragem.
Yuishin Izumi, MD, PhD No disclosure on file
Harald Hegen, MD Dr. Hegen has nothing to disclose.
Gabriel Bsteh, MD Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Nik Krajnc Nik Krajnc has nothing to disclose.
Patrick Altmann The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Michael Auer Michael Auer has nothing to disclose.
Klaus Berek Klaus Berek has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Klaus Berek has received personal compensation in the range of $500-$4,999 for serving as a travel compensation with Roche, Teva, Merck, Biogen, Sanofi, Novartis.
Barbara Kornek, MD Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS Celgene. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson&Johnson. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kornek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Kornek has received research support from Novartis.
Fritz Leutmezer Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Stefan Macher Stefan Macher has nothing to disclose.
Tobias Monschein No disclosure on file
Markus Ponleitner Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics, Inc.. Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus Therapeutics Inc.. Markus Ponleitner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Markus Ponleitner has received research support from European Academy of Neurology.
Paulus S. Rommer Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Christiane Schmied No disclosure on file
Karin Zebenholzer, MD Dr. Zebenholzer has nothing to disclose.
Gudrun Zulehner No disclosure on file
Tobias Zrzavy Tobias Zrzavy has nothing to disclose.
Florian Deisenhammer, MD Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Deisenhammer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Deisenhammer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Deisenhammer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SOBI.
Franziska Di Pauli Franziska Di Pauli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for horizon. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. Franziska Di Pauli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Franziska Di Pauli has received research support from Roche.
Berthold Pemp, MD Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Pemp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GenSight. The institution of Dr. Pemp has received research support from Chiesi.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Chahin Pachai Chahin Pachai has received personal compensation for serving as an employee of Bristol Myers Squibb. Chahin Pachai has stock in Bristol-Myers Squibb.
Nathanial Eddy Nathanial Eddy has received personal compensation for serving as an employee of Bristol Myers Squibb. Nathanial Eddy has stock in Bristol Myers Squibb.
Jason Osik Jason Osik has received personal compensation for serving as an employee of Bristol Myers Squibb. Jason Osik has stock in Bristol Myers Squibb. Jason Osik has received intellectual property interests from a discovery or technology relating to health care.
Chun-Yen Cheng Chun-Yen Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Chun-Yen Cheng has stock in Bristol Myers Squibb.
Sarah Harris Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Erik Deboer Erik Deboer has received personal compensation for serving as an employee of BMS.
Leorah A. Freeman, MD, PhD Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono/ Merck. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. The institution of Dr. Freeman has received research support from Sanofi. The institution of Dr. Freeman has received research support from MSAA. The institution of Dr. Freeman has received research support from National Multiple Sclerosis Society.
Cristina Granziera, MD, PhD The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Rosalind Mandelbaum No disclosure on file
Katherine Beshears Ms. Beshears has nothing to disclose.
Mandy Koop No disclosure on file
Kelsey Owen No disclosure on file
Jay L. Alberts, PhD Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceraxis. Dr. Alberts has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceraxis. The institution of Dr. Alberts has received research support from NIH. The institution of Dr. Alberts has received research support from Department of Defense. The institution of Dr. Alberts has received research support from Michael J. Fox Foundation. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive.
Marisa P. McGinley, DO Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Margaux Poleur No disclosure on file
Barbara Willekens, MD, PhD, FAAN The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Dr. Willekens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall . The institution of Dr. Willekens has received research support from Roche. The institution of Dr. Willekens has received research support from Janssen. Dr. Willekens has a non-compensated relationship as a Co-chair scientific panel of neuroimmunology with European Academy of Neurology that is relevant to AAN interests or activities.
Bertrand Degos No disclosure on file
Damien Ricard, MD No disclosure on file
Vincent Van Pesch, MD, PhD Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Emilie Lommers No disclosure on file
Celine Cluzeau No disclosure on file
Damien Eggenspieler No disclosure on file
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Mona Michaud No disclosure on file
Hui Li No disclosure on file
Laurie Medard No disclosure on file
Alexis Tricot No disclosure on file
Paul Strijbos No disclosure on file
James Overell, MD, MBBS Dr. Overell has received personal compensation for serving as an employee of Roche. Dr. Overell has stock in Roche.
Alejandro Ena Bernad No disclosure on file
Tim Woelfle The institution of Dr. Woelfle has received research support from Foundation Clinical Neuroimmunology and Neuroscience Basel. The institution of Dr. Woelfle has received research support from Swiss Innovation Agency (Innosuisse) – Project ID: 33535.1 IP-ICT.
Johannes Lorscheider The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Johannes Lorscheider has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Johannes Lorscheider has received research support from Innosuisse - Swiss Innvation Ageny. The institution of Johannes Lorscheider has received research support from MSBase Foundation. The institution of Johannes Lorscheider has received research support from Novartis.
Ana Barragan No disclosure on file
Óscar G. Reyes Pupo, PhD Dr. Reyes Pupo has nothing to disclose.
Albert Lo, MD, PhD No disclosure on file
Sarah Levy, PhD Dr. Levy has nothing to disclose.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Ilana B. Katz Sand, MD The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with 好色先生.
Omer Berkman No disclosure on file
Eitan Raveh No disclosure on file
Edmund Ben-Ami No disclosure on file
Rivka Kreitman No disclosure on file
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Scott S. Zamvil, MD, PhD, FAAN Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Alit Bhatt Alit Bhatt has nothing to disclose.
Wenjia Wei Wenjia Wei has received personal compensation for serving as an employee of Novartis.
Ibolya Boer, MD Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Carmenrita Infortuna Carmenrita Infortuna has nothing to disclose.
ANITA GRACEFFA No disclosure on file
Maria Buccafusca No disclosure on file
Enrica Maiorana No disclosure on file
Antonio Bruno No disclosure on file
Florian P. Thomas, MD, PhD, MA, FAAN Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Fortunato Battaglia, MD Dr. Battaglia has nothing to disclose.
Alyssa Nylander, MD, PhD Dr. Nylander has nothing to disclose.
Kyra Henderson Kyra Henderson has nothing to disclose.
Kanishka Koshal No disclosure on file
Nikki Sisodia Nikki Sisodia has nothing to disclose.
Jaeleene Wijangco Jaeleene Wijangco has nothing to disclose.
Shane Poole Shane Poole has nothing to disclose.
Jim Rowson No disclosure on file
Cathra Halabi, MD The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Ethan G. Brown, MD Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. Dr. Brown has stock in 153 Therapeutics. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Katherine L. Possin, PhD Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
Adam Staffaroni Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Jon Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Jennifer L. Reardon Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Andrew Thorpe No disclosure on file
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Mie R. Mahler, MD The institution of Miss Mahler has received research support from Copenhagen University Hospital - Rigshospitalet's research fund. Miss Mahler has a non-compensated relationship as a participant in a scientific meeting with Merck that is relevant to AAN interests or activities.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Luigi Pontieri No disclosure on file
Frederik Elberling No disclosure on file
Arkadiusz Weglewski Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Weglewski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Weglewski has received publishing royalties from a publication relating to health care. Dr. Weglewski has received publishing royalties from a publication relating to health care.
Mai Bang Poulsen No disclosure on file
Plamen Bekyarov No disclosure on file
Zsolt Illes, MD No disclosure on file
Matthias Kant Matthias Kant has nothing to disclose.
Tobias Sejbaek, MD, PhD Prof. Sejbaek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Merck, NeuroXpharm, Novartis, Roche, Sandoz and Sanofi. The institution of Prof. Sejbaek has received research support from Merck, Novartis, Roche and Sanofi.
Morten Leif Munding Stilund Morten Leif Munding Stilund has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicinske Tidsskrifter.
Peter V. Rasmussen, MD Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Rasmussen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Maria Pedersen No disclosure on file
Inga Urbonaviciute No disclosure on file
Finn Sellebjerg, MD Dr. Sellebjerg has received personal compensation for serving as an employee of Danish Multiple Sclerosis Society. Dr. Sellebjerg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sellebjerg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Gangsted Foundation. Dr. Sellebjerg has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Warwara Larsen Foundation. The institution of Dr. Sellebjerg has received research support from Biogen. The institution of Dr. Sellebjerg has received research support from Merck. The institution of Dr. Sellebjerg has received research support from Novartis. The institution of Dr. Sellebjerg has received research support from Sanofi Genzyme. Dr. Sellebjerg has received publishing royalties from a publication relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Hanaan Bing-Canar, PhD Dr. Bing-Canar has nothing to disclose.
Marwa Baalbaki, MD Dr. Baalbaki has nothing to disclose.
Christine Nguyen Miss Nguyen has nothing to disclose.
Brandon Molligoda Mr. Molligoda has nothing to disclose.
Noah Kim No disclosure on file
Eva Kitlen No disclosure on file
Charles Wira Charles Wira has nothing to disclose.
Sarah Perman No disclosure on file
Akhil Khosla Akhil Khosla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inari.
P Elliott Miller P Elliott Miller has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JCF-I.
David M. Greer, MD, FAAN Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Siena Duarte, MD, MAS Dr. Duarte has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Duarte has received personal compensation for serving as an employee of University of California, San Francisco.
Ze Ou, DBBS Mr. Ou has nothing to disclose.
Sung-Min Cho No disclosure on file
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN Dr. Ritzl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.
Romergryko G. Geocadin, MD, FAAN Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
Ping Zhuang, PhD Dr. Zhuang has nothing to disclose.
Nirmala Ghimirey, DO Dr. Ghimirey has nothing to disclose.
Christopher R. Newey, DO Dr. Newey has nothing to disclose.
Harinoor Mann, MBBS Dr. Mann has nothing to disclose.
Vinh Nguyen No disclosure on file
Madihah A. Hepburn, MD Dr. Hepburn has nothing to disclose.
Helena Xeros, MD Dr. Xeros has nothing to disclose.
Sherri A. Braksick, MD, FAAN Dr. Braksick has nothing to disclose.
Eelco F. Wijdicks, MD, FAAN Dr. Wijdicks has received publishing royalties from a publication relating to health care.
May Zin Myint, MBBS Dr. Myint has nothing to disclose.
Vijay Sharma No disclosure on file
Shir Lynn Lim No disclosure on file
Chiew Hong No disclosure on file
Young Heng Chee No disclosure on file
Yugant Khand, MBBS, DiMM Dr. Khand has nothing to disclose.
Priya Mainali No disclosure on file
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Courtney E. McIlduff, MD The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Elijah Stommel, MD, FAAN Dr. Stommel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Suslick Attorney. The institution of Dr. Stommel has received research support from CDC.
Ethan Murphy No disclosure on file
Sarah Verga Miss Verga has nothing to disclose.
Soleil Samaan No disclosure on file
Allaire Doussan No disclosure on file
Kathy Phipps No disclosure on file
Christy Smith No disclosure on file
Sean Levy No disclosure on file
Ajitesh Nanda Ajitesh Nanda has nothing to disclose.
Teresa Capella Teresa Capella has nothing to disclose.
Ryan Halter No disclosure on file
Amanda Tinsley, MD No disclosure on file
Baljinder Singh, MD Dr. Singh has nothing to disclose.
Rajeev Motiwala, MD, FAAN Dr. Motiwala has nothing to disclose.
Yixin Chen No disclosure on file
Xueying Liu No disclosure on file
MaryLynn Chu, MD Dr. Chu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics; PTC Therapeutics,Inc..
Harmandeep Singh Brar No disclosure on file
Jacqueline Kraus, MD, PhD Dr. Kraus has a non-compensated relationship as a Member with AAN that is relevant to AAN interests or activities.
Bassam Malo, MD No disclosure on file
Kevin A. Mazurek, PhD Dr. Mazurek has received personal compensation for serving as an employee of Delos Living / Well Living Lab. Dr. Mazurek has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Mazurek has a non-compensated relationship as a Editor with AAN Resident and Fellows Section that is relevant to AAN interests or activities.
Jennifer M. Martinez-Thompson, MD, FAAN Dr. Martinez-Thompson has nothing to disclose.
Carolina Parra Cantu, MD Dr. Cantu has nothing to disclose.
Venkatsampath Raja Gogineni Venkatsampath Raja Gogineni has nothing to disclose.
Hugo Botha, MD Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Leland Barnard Leland Barnard has nothing to disclose.
Nathan P. Staff, MD, PhD, FAAN Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Maurizio Grassano, MD Dr. Grassano has received research support from American Brain Foundation, ALS Association and 好色先生.
Francesca Palumbo Dr. Palumbo has nothing to disclose.
Paolina Salamone No disclosure on file
Cristina Moglia Cristina Moglia has nothing to disclose.
Giuseppe Fuda No disclosure on file
Federico Casale No disclosure on file
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Antonio Canosa Antonio Canosa has nothing to disclose.
Letizia Mazzini No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Emily L. McGinnis, MD No disclosure on file
Christian Krarup, MD, DMSc, FRcP, FAAN Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Birgit Andersen No disclosure on file
Sudha Kessler, MD Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. The institution of Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson, Elser. The institution of Dr. Kessler has received research support from FDA, Commonwealth of Pennsylvania, Epilepsy Study Consortium, UCB Pharma, Greenwich Biosciences, Eisai Co. Ltd.. PCORI/AHRQ, SK Life. Dr. Kessler has a non-compensated relationship as a volunteer committee member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Kessler has a non-compensated relationship as a committee member with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Xiaoyan Li, MD Dr. Li has nothing to disclose.
Baggio Evangelista No disclosure on file
Rebecca Traub, MD, FAAN Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Natalie Stanley No disclosure on file
Rick Meeker No disclosure on file
Todd Cohen No disclosure on file
Pardis Pooshpas, MD Dr. Pooshpas has nothing to disclose.
Said R. Beydoun, MD, FAAN Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Leila Darki, MD, FAAN Dr. Darki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partner. Dr. Darki has received personal compensation in the range of $0-$499 for serving as a Consultant for Guide point Global. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Access Meetings. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx . Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx.
Brett A. McCray, MD The institution of Dr. McCray has received research support from NIH. The institution of Dr. McCray has received research support from Johns Hopkins Merkin Peripheral Neuropathy and Nerve Regeneration Center. The institution of Dr. McCray has received research support from Muscular Dystrophy Association.
Denizart Santos-Neto, MD Dr. Santos-Neto has nothing to disclose.
Manav Vyas, MD The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Ario Mirian, MD Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Mirian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson.
Agessandro Abrahao, Jr., MD Dr. Abrahao has nothing to disclose.
Lorne H. Zinman, MD Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Pedro Saldanha de Castro No disclosure on file
Pashtun-Poh Shahim, MD, PhD Pashtun-Poh Shahim has nothing to disclose.
Gina Norato Gina Norato has nothing to disclose.
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Kaj Blennow Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Christopher Grunseich, MD The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Leighton Chan No disclosure on file
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Kristiana Salmon, Other Miss Salmon has received personal compensation for serving as an employee of QurAlis Corporation. Miss Salmon has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ProJenX. Miss Salmon has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with ALS Canada.
John Polzer No disclosure on file
Clarida Martinez No disclosure on file
Bryan Boggs No disclosure on file
Victoria C. Eon, CRC Ms. Eon has received personal compensation for serving as an employee of QurAlis Corporation.
Rakhee Ganti No disclosure on file
Sandy Hinckley No disclosure on file
Kristina Johnson Ms. Johnson has received personal compensation for serving as an employee of QurAlis. Ms. Johnson has stock in QurAlis.
Dan Elbaum No disclosure on file
Rejean M. Guerriero, MD Dr. Guerriero has nothing to disclose.
Ilene Hollin The institution of Ilene Hollin has received research support from MT Pharma. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from PCORI. The institution of Ilene Hollin has received research support from Shriners Hospital for Children. The institution of Ilene Hollin has received research support from NIH/NIDDK. The institution of Ilene Hollin has received research support from NIH/NHLBI. Ilene Hollin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with New Horizons, a division of Global Health Labs.
Laura Chisholm Laura Chisholm has nothing to disclose.
Anudeeta Gautam Miss Gautam has nothing to disclose.
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Piera Pasinelli The institution of Dr. Pasinelli has received research support from NIH-NINDS.
Hristelina S. Ilieva, MD The institution of Dr. Ilieva has received research support from ALSA. Dr. Ilieva has received personal compensation in the range of $0-$499 for serving as a reviewer with DOD.
Miya Bernson-Leung, MD, FAAN An immediate family member of Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Bernson-Leung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioMarin. Dr. Bernson-Leung has stock in Abbott Labs. Dr. Bernson-Leung has stock in Abbvie Inc.
Eduardo R. Locatelli, MD An immediate family member of Dr. Locatelli has received personal compensation for serving as an employee of Pfizer. The institution of Dr. Locatelli has received research support from ALS association. The institution of Dr. Locatelli has received research support from Department of Defense.
Gabriela Lopes, NP Mrs. Lopes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceutical.
Lauren T. Gray, PhD Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alabama Dysphagia Conference. The institution of Dr. Gray has received research support from ALS Association. The institution of Dr. Gray has received research support from Department of Defense. The institution of Dr. Gray has received research support from ALS Association.
Danielle B. Pier, MD No disclosure on file
Eufrosina I. Young, MD The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Dongliang Wang Dongliang Wang has nothing to disclose.
Birendra Sah Birendra Sah has received publishing royalties from a publication relating to health care.
Dragos Manta Dragos Manta has nothing to disclose.
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
George P. Slavinski, Respiratory Therapist Mr. Slavinski has nothing to disclose.
Lena Deb Lena Deb has nothing to disclose.
Marielle Posmik Marielle Posmik has nothing to disclose.
Takuya Kudo Mr. Kudo has nothing to disclose.
Kinjal Patel Kinjal Patel has nothing to disclose.
Stephen Apple Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
Moon Han, PhD Dr. Han has nothing to disclose.
Jaime Raymond Jaime Raymond has nothing to disclose.
Jasmine Berry Jasmine Berry has nothing to disclose.
Theodore Larson Theodore Larson has nothing to disclose.
D Kevin Horton No disclosure on file
Paul Mehta Paul Mehta has nothing to disclose.
Reshma Punjani Reshma Punjani has nothing to disclose.
Rabia Malik, MD Dr. Malik has nothing to disclose.
Abeeha Mirza No disclosure on file
Kiran P. Maski, MD An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
Frances M. Aponte-Caraballo, MS Miss Aponte-Caraballo has received personal compensation for serving as an employee of Fundación ALS de Puerto Rico. Miss Aponte-Caraballo has received research support from AIM-AHEAD Data Science Training Core Training Practicum (PRIME) Program.
Rosa Rosario-Rosado No disclosure on file
ISTONI DA LUZ SANTANA No disclosure on file
Brenda Deliz Roldan No disclosure on file
David K. Urion, MD, FAAN Dr. Urion has nothing to disclose.
Gary L. Pattee, MD The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Tom Petro No disclosure on file
Ahmed Esmael No disclosure on file
Irina Agarkova No disclosure on file
David Dunigan No disclosure on file
Fabrizio Chiodo No disclosure on file
Cristina De Castro No disclosure on file
James Van Etten No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Jamie Wong, PhD Dr. Wong has nothing to disclose.
Annie E. McDermott Ms. McDermott has nothing to disclose.
Sarah M. Kovalev, RA Miss Kovalev has nothing to disclose.
Gillian Ciaccio No disclosure on file
Shashishekha J. Lamdhade, MD No disclosure on file
Samantha Rubino No disclosure on file
Abdulaziz Ashkanani, BMBCH, FRCPC, FAAN No disclosure on file
Blaine Cloud, PhD Dr. Cloud has nothing to disclose.
Alissa Algarin No disclosure on file
Frank J. Franzino III, Other Mr. Franzino has nothing to disclose.
Crystal T. Wong, MD No disclosure on file
Jessica White, MD Dr. White has nothing to disclose.
Vaishnavi Rao No disclosure on file
Ryan Ransom No disclosure on file
Giuseppe Lanzino, MD Dr. Lanzino has nothing to disclose.
Michael W. Ruff, MD Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Ashis H. Tayal, MD Dr. Tayal has nothing to disclose.
Aparna Kalyani Pariyadath, MBBS Dr. Pariyadath has nothing to disclose.
Christian Amlang, MD Dr. Amlang has nothing to disclose.
Nicholas L. Zalewski, MD Dr. Zalewski has nothing to disclose.
Sarah Mauney, DO Dr. Mauney has nothing to disclose.
Lydia Kauffman, MD Dr. Kauffman has nothing to disclose.
James Grogan, MD Dr. Grogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Max R. Lowden, MD, FAAN Dr. Lowden has nothing to disclose.
Julie C Fanburg-Smith No disclosure on file
Kimberly Harbough No disclosure on file
Philion Gatchoff, MD Dr. Gatchoff has nothing to disclose.
Estevao P. Ribeiro, MD Dr. Ribeiro has nothing to disclose.
Evan Fields, MD Dr. Fields has nothing to disclose.
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Priscilla Yan, MD Dr. Yan has nothing to disclose.
Christian A. Sam, MD Dr. Sam has nothing to disclose.
Surjeet Kundi, MD Dr. Kundi has nothing to disclose.
Elizabeth H. Morrison-Banks, MD, MSEd Dr. Morrison-Banks has nothing to disclose.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Hadi M. Mohammad Khanli, MD Dr. Mohammad Khanli has nothing to disclose.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Amber R. Hughes Miss Hughes has nothing to disclose.
Manisha Satheesh, = Ms. Satheesh has nothing to disclose.
Benjamin A. Hull Mr. Hull has nothing to disclose.
Sofia Aranda No disclosure on file
Spencer Brown No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Shravan Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Kajol H. Doshi, MD Dr. Doshi has nothing to disclose.
James Lanska No disclosure on file
Nicholas J. Bellacicco, DO Dr. Bellacicco has nothing to disclose.
Zachary Lodato, DO Dr. Lodato has nothing to disclose.
Machteld E. Hillen, MD, FAAN The institution of Dr. Hillen has received research support from Genentech.
Hariharan Venkataraman, MBBS Mr. Venkataraman has nothing to disclose.
Douglas J. Lanska, MD, FAAN Dr. Lanska has received personal compensation for serving as an employee of Ministry of Health of the Russian Federation. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedScape 好色先生. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebix/Oakstone Publishing. Dr. Lanska has received publishing royalties from a publication relating to health care. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Mayo Clinic.
Mittal S. Prajapati, MD Dr. Prajapati has nothing to disclose.
Joseph Thirumalareddy No disclosure on file
Bernd F. Remler, MD No disclosure on file
Rhonna S. Shatz, DO Dr. Shatz has nothing to disclose.
Sophie Kushman No disclosure on file
Alique G. Topalian, PhD, MPH Dr. Topalian has nothing to disclose.
Luanne Metz, MD The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Andrew Dhawan, MD Dr. Dhawan has nothing to disclose.
Radhika Amin, MPH Ms. Amin has nothing to disclose.
Surabhi Ranjan, MD Dr. Ranjan has nothing to disclose.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Sara Hardy, MD Dr. Hardy has received research support from the American Cancer Society.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Derek L. Chien Mr. Chien has nothing to disclose.
Nimish A. Mohile, MD, FAAN The institution of Dr. Mohile has received research support from Novocure.
Lauryn Hemminger Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
David K. Li, MD Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Justin D. Bessette Mr. Bessette has nothing to disclose.
Julia Noreck Julia Noreck has nothing to disclose.
Tara Szymanski No disclosure on file
Eric T. Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
William Siwik No disclosure on file
Robert Edwards No disclosure on file
Pierre Duquette, MD The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Sreya Devarakonda Miss Devarakonda has nothing to disclose.
Adam L. Cohen, MD The institution of Dr. Cohen has received research support from Chimerix. An immediate family member of Dr. Cohen has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NIH. Dr. Cohen has received personal compensation in the range of $100,000-$499,999 for serving as a EMployee with Inova.
Thomas Wychowski, MD The institution of Dr. Wychowski has received research support from UCB.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Joy E. Burke, MD No disclosure on file
Andrea C. Wasilewski, MD Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Michael McDermott No disclosure on file
Marcelo C. Kremenchutzky, MD, FAAN No disclosure on file
John Paul Aboubechara, MD, PhD Dr. Aboubechara has nothing to disclose.
Orwa Aboud, MD, PhD Dr. Aboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aboud LLC.
Galina Vorobeychik, MD, FRCPC, FAAN Dr. Vorobeychik has nothing to disclose.
Jordanne Kirschke Ms. Kirschke has nothing to disclose.
Vanessa Kirschke Ms. Kirschke has nothing to disclose.
Ian George No disclosure on file
Megumi Sugita, DO Dr. Sugita has nothing to disclose.
Eric Lipp No disclosure on file
Katherine B. Peters, MD, PhD, FAAN Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.
Nada El Husseini, MD, FAAN Dr. El Husseini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH. The institution of Dr. El Husseini has received research support from American Heart Association. The institution of Dr. El Husseini has received research support from PCORI.
Dylan T. Ryan, MD Dr. Ryan has nothing to disclose.
Virender Bhan, MD Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bhan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi.
Gregg G. Blevins, MD, FRCP(C) Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Dan Tong Jia, MD Dr. Jia has nothing to disclose.
Roumen D. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Karan S. Dixit, MD Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Jayesh Mehta No disclosure on file
Eyal Y. Kimchi, MD, PhD The institution of Dr. Kimchi has received research support from NIH. The institution of an immediate family member of Dr. Kimchi has received research support from NIH.
James Marriott, MD, MSc Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis.
Forat Lutfi No disclosure on file
Dustin Begosh-Mayne No disclosure on file
You Hernandez No disclosure on file
Juan Perez Hernandez No disclosure on file
Ambar M. MORALES-RODRIGUEZ, MD Dr. MORALES-RODRIGUEZ has nothing to disclose.
Francois Grand-Maison, MD Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Courtney N. Nguyen Ms. Nguyen has nothing to disclose.
Abraham John, MD, MHA Dr. John has nothing to disclose.
Shivika Chandra, MD, FAAN The institution of Dr. Chandra has received research support from American Board of Psychiatry and Neurology Faculty Innovation in 好色先生 Award. The institution of Dr. Chandra has received research support from Michael J Fox Foundation.
Liesly Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
My H. Nguyen Miss Nguyen has nothing to disclose.
Jerome J. Graber, MD, MPH, FAAN Dr. Graber has received personal compensation for serving as an employee of Binaytara Foundation. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurological Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with 好色先生 that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Manon Thibault, MD No disclosure on file
Anza Zahid, MD, MBBS Dr. Zahid has nothing to disclose.
Sudhakar Tummala, MD, FAAN Dr. Tummala has nothing to disclose.
Mainak Bardhan, MD Dr. Bardhan has nothing to disclose.
Amina Namrouti, MD Miss Namrouti has nothing to disclose.
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Yazmin Odia, MD, MS, MBA, FAAN Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile. Dr. Odia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimeric, part of Jazz Pharmaceuticals.
Ashish D. Patel, MD An immediate family member of Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Patel has stock in Ocular Therapeutix. Dr. Patel has stock in Autolus Therapeutics . Dr. Patel has stock in Larimar Therapeutics. Dr. Patel has stock in Viking Therapeutics. An immediate family member of Dr. Patel has stock in Voyager Therapeutics. An immediate family member of Dr. Patel has stock in BridgeBio Pharma, Inc.. An immediate family member of Dr. Patel has stock in Stoke Therapeutics. The institution of an immediate family member of Dr. Patel has received research support from The Patient-Centered Outcomes Research Institute.
Neil R. Holland, MBBS, FAAN Dr. Holland has nothing to disclose.
Megan E. Esch, MD The institution of Dr. Esch has received research support from PCORI.
Bavica Gummadi, DO Dr. Gummadi has nothing to disclose.
Raissa Aoun, MD Dr. Aoun has nothing to disclose.
Samuel Wiebe, MD Dr. Wiebe has a non-compensated relationship as a Past President with International League Against Epilepsy that is relevant to AAN interests or activities.
Saori L. Haigo, MD, PhD Dr. Haigo has nothing to disclose.
Rumyar V. Ardakani, MD Dr. Ardakani has nothing to disclose.
Daniel Pastula, MD, MHS, FAAN Dr. Pastula has nothing to disclose.
Daniel Pollyea No disclosure on file
Zenggang Pan No disclosure on file
Saif S. Bawaneh, MD Dr. Bawaneh has nothing to disclose.
Yu-Ting Chen, MD Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Guojun Zhao, MD No disclosure on file
Catherine Joseph, NP Ms. Joseph has nothing to disclose.
Merry Chen, MD Dr. Chen has nothing to disclose.
Rutu Patel, PA Ms. Patel has nothing to disclose.
Jamie Greenfield No disclosure on file
Jay-Jiguang Zhu, MD, PhD, FAAN The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Binoy Yohannan No disclosure on file
Allen Omo-Ogboi No disclosure on file
Sameeksha Bhama No disclosure on file
Xinhai Zhang No disclosure on file
Joshua Nahm No disclosure on file
Swapna L. Putta, MD No disclosure on file
Adriana C. Rodriguez Leon, MD Dr. Rodriguez Leon has nothing to disclose.
Joan Maley No disclosure on file
Aygun Asgarli, MD Dr. Asgarli has nothing to disclose.
Matthew J. Thurtell, MD Dr. Thurtell has received publishing royalties from a publication relating to health care.
Nhayoung Hwang, MD Dr. Hwang has nothing to disclose.
Yin A. Liu, MD, FAAN Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Monica Tran No disclosure on file
Allan Fisher No disclosure on file
Tracey A. Milligan, MD, FAAN Dr. Milligan has received publishing royalties from a publication relating to health care.
Naga Pradyumna Kothapalli, MD Dr. Kothapalli has nothing to disclose.
Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Shannon M. Beres, MD Dr. Beres has nothing to disclose.
Philip T. Kuball, MD Dr. Kuball has nothing to disclose.
Ruben Jauregui, MD Dr. Jauregui has nothing to disclose.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Scott Grossman, MD Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Vito P. Arena, MD Dr. Arena has nothing to disclose.
Evan Stein No disclosure on file
Christopher William Christopher William has nothing to disclose.
Isabella Canut Ms. Canut has nothing to disclose.
Blaire Cote No disclosure on file
Bijen Nazliel No disclosure on file
JoBeth D. Bingham, DO Dr. Bingham has nothing to disclose.
Jillian Prier, MD Dr. Prier has nothing to disclose.
Maha Alattar, MD Dr. Alattar has nothing to disclose.
Raymond Hupperts No disclosure on file
Danielle Silverman Ms. Silverman has nothing to disclose.
Jennifer Da No disclosure on file
Vanessa Merker The institution of Vanessa Merker has received research support from Children's Tumor Foundation . The institution of Vanessa Merker has received research support from NF Northeast. The institution of Vanessa Merker has received research support from Patient Centered Outcomes Research Institute. The institution of Vanessa Merker has received research support from U.S. Department of Defense . The institution of Vanessa Merker has received research support from Neurofibromatosis Therapeutic Accleration Project. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a Science Writer with Neurofibromatosis Network.
Ina Ly, MD An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care.
Alona Muzikansky No disclosure on file
Michael Parsons No disclosure on file
Pamela Wolters No disclosure on file
Lei Xu No disclosure on file
Mark T. Brown, MD Dr. Brown has received personal compensation for serving as an employee of Pfizer Inc. Dr. Brown has received stock or an ownership interest from Pfizer Inc.
Mehrdad Haghpassand No disclosure on file
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Children's Hospital. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Continental Casualty Company. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for HennLesperance. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Rhoades McKee. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell. Dr. Jordan has or had stock in Navio Theragnostics. An immediate family member of Dr. Jordan has or had stock in OldGate.Dr. Jordan has or had stock in Shepherd Therapeutics.Dr. Jordan has or had stock in Khora TX. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received publishing royalties from a publication relating to health care.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Ulrich Fulda, MD No disclosure on file
Kai McGreevy, MD Dr. McGreevy has nothing to disclose.
Joanna E. Bielewicz, PhD Dr. Bielewicz has nothing to disclose.
Beata Daniluk No disclosure on file
Piotr Kamieniak No disclosure on file
Pichet Termsarasab, MD No disclosure on file
Suraj Malhan, DO Dr. Malhan has nothing to disclose.
Beth B. Hogans, MD, PhD Dr. Hogans has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Pain Medicine. The institution of Dr. Hogans has received research support from VA Office of Research and Development. Dr. Hogans has received intellectual property interests from a discovery or technology relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has received publishing royalties from a publication relating to health care. Dr. Hogans has a non-compensated relationship as a Grant reviewer with Veterans Affairs Office of Research and Development that is relevant to AAN interests or activities. Dr. Hogans has a non-compensated relationship as a Grant reviewer with National Institutes of Health that is relevant to AAN interests or activities.
Bernadette Siaton No disclosure on file
John Sorkin No disclosure on file
Steven Frucht, MD Dr. Frucht has nothing to disclose.
Sailaja Sanikommu, MBBS Dr. Sanikommu has nothing to disclose.
Kevin Sheng-Kai Ma Dr. MA has nothing to disclose.
Gouthami Sajjanagandla No disclosure on file
Rajan Chamlagain No disclosure on file
Kathleen Sullivan No disclosure on file
Walter Maier-Janson, MD Dr. Maier-Janson has nothing to disclose.
Tarso Adoni, MD, PhD, FAAN Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Wael Richeh, MD Dr. Richeh has nothing to disclose.
Tyler Arnwine No disclosure on file
Mark Girgis, DO Dr. Girgis has nothing to disclose.
Amr Salem, MBBCH Dr. Salem has nothing to disclose.
Stephanie Gandelman, MD Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen.
Fang Yu, MD Fang Yu has nothing to disclose.
Krishna Dahal No disclosure on file
Sangam Shah Dr. Shah has nothing to disclose.
Sangharsha Thapa, MD Dr. Thapa has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Samantha Sweeney, Other Dr. Sweeney has received personal compensation for serving as an employee of Pfizer. Dr. Sweeney has stock in Pfizer.
James Appio James Appio has received personal compensation for serving as an employee of Bristol Myers Squibb. James Appio has stock in Bristol Myers Squibb.
Shannon Giliberto Mrs. Giliberto has nothing to disclose.
Tina Singh No disclosure on file
Sadeepa Bulathsinhala No disclosure on file
Jonathan Terry No disclosure on file
Rhea Shishodia No disclosure on file
Abel M. Thomas Mr. Thomas has nothing to disclose.
John A. Flatt, MD No disclosure on file